Inflammatory response time course, HUVEC (Wada et al., 2009)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
ZNF711
|
ENSG00000147180.12 | zinc finger protein 711 |
TFAP2A
|
ENSG00000137203.6 | transcription factor AP-2 alpha |
TFAP2D
|
ENSG00000008197.4 | transcription factor AP-2 delta |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
ZNF711 | hg19_v2_chrX_+_84498989_84499003, hg19_v2_chrX_+_84499038_84499078 | 0.53 | 6.0e-03 | Click! |
TFAP2D | hg19_v2_chr6_+_50681541_50681541 | -0.30 | 1.5e-01 | Click! |
TFAP2A | hg19_v2_chr6_-_10415218_10415274 | 0.29 | 1.6e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr4_+_156588350 | 15.94 |
ENST00000296518.7
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr1_+_25944341 | 15.86 |
ENST00000263979.3
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
chr4_+_156588806 | 13.14 |
ENST00000513574.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr4_+_156588249 | 9.47 |
ENST00000393832.3
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr17_-_42276574 | 8.44 |
ENST00000589805.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr9_+_139606983 | 8.04 |
ENST00000371692.4
|
FAM69B
|
family with sequence similarity 69, member B |
chr6_-_84419101 | 7.79 |
ENST00000520302.1
ENST00000520213.1 ENST00000439399.2 ENST00000428679.2 ENST00000437520.1 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr9_-_140196703 | 7.76 |
ENST00000356628.2
|
NRARP
|
NOTCH-regulated ankyrin repeat protein |
chr2_+_112656048 | 7.42 |
ENST00000295408.4
|
MERTK
|
c-mer proto-oncogene tyrosine kinase |
chr4_+_156588115 | 7.39 |
ENST00000455639.2
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr14_-_105635090 | 7.29 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
chr10_-_33625154 | 7.11 |
ENST00000265371.4
|
NRP1
|
neuropilin 1 |
chr20_-_39317868 | 7.07 |
ENST00000373313.2
|
MAFB
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog B |
chr1_+_78511586 | 7.02 |
ENST00000370759.3
|
GIPC2
|
GIPC PDZ domain containing family, member 2 |
chr14_+_24867992 | 7.01 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr11_-_2906979 | 6.94 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr7_+_30960915 | 6.93 |
ENST00000441328.2
ENST00000409899.1 ENST00000409611.1 |
AQP1
|
aquaporin 1 (Colton blood group) |
chr18_+_77160282 | 6.78 |
ENST00000318065.5
ENST00000545796.1 ENST00000592223.1 ENST00000329101.4 ENST00000586434.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr20_-_23030296 | 6.73 |
ENST00000377103.2
|
THBD
|
thrombomodulin |
chr2_+_112656176 | 6.73 |
ENST00000421804.2
ENST00000409780.1 |
MERTK
|
c-mer proto-oncogene tyrosine kinase |
chr18_+_59992527 | 6.56 |
ENST00000586569.1
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
chr17_-_42277203 | 6.18 |
ENST00000587097.1
|
ATXN7L3
|
ataxin 7-like 3 |
chr18_+_77155856 | 6.05 |
ENST00000253506.5
ENST00000591814.1 |
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr6_+_142622991 | 5.92 |
ENST00000230173.6
ENST00000367608.2 |
GPR126
|
G protein-coupled receptor 126 |
chr10_-_131762105 | 5.79 |
ENST00000368648.3
ENST00000355311.5 |
EBF3
|
early B-cell factor 3 |
chr14_-_54420133 | 5.76 |
ENST00000559501.1
ENST00000558984.1 |
BMP4
|
bone morphogenetic protein 4 |
chr1_-_33168336 | 5.73 |
ENST00000373484.3
|
SYNC
|
syncoilin, intermediate filament protein |
chr11_+_59522900 | 5.67 |
ENST00000529177.1
|
STX3
|
syntaxin 3 |
chr12_+_53443963 | 5.62 |
ENST00000546602.1
ENST00000552570.1 ENST00000549700.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr4_+_42399856 | 5.56 |
ENST00000319234.4
|
SHISA3
|
shisa family member 3 |
chr3_+_37903432 | 5.56 |
ENST00000443503.2
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like |
chr17_-_5487277 | 5.53 |
ENST00000572272.1
ENST00000354411.3 ENST00000577119.1 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr12_+_20522179 | 5.53 |
ENST00000359062.3
|
PDE3A
|
phosphodiesterase 3A, cGMP-inhibited |
chrX_+_149531524 | 5.50 |
ENST00000370401.2
|
MAMLD1
|
mastermind-like domain containing 1 |
chr6_+_142623063 | 5.47 |
ENST00000296932.8
ENST00000367609.3 |
GPR126
|
G protein-coupled receptor 126 |
chr8_-_81083341 | 5.37 |
ENST00000519303.2
|
TPD52
|
tumor protein D52 |
chr14_-_91526462 | 5.33 |
ENST00000536315.2
|
RPS6KA5
|
ribosomal protein S6 kinase, 90kDa, polypeptide 5 |
chr22_+_51112800 | 5.32 |
ENST00000414786.2
|
SHANK3
|
SH3 and multiple ankyrin repeat domains 3 |
chr4_+_156587979 | 5.10 |
ENST00000511507.1
|
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr18_+_11981427 | 5.09 |
ENST00000269159.3
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr20_+_42544782 | 5.07 |
ENST00000423191.2
ENST00000372999.1 |
TOX2
|
TOX high mobility group box family member 2 |
chr1_+_2160134 | 5.04 |
ENST00000378536.4
|
SKI
|
v-ski avian sarcoma viral oncogene homolog |
chr4_+_6271558 | 5.02 |
ENST00000503569.1
ENST00000226760.1 |
WFS1
|
Wolfram syndrome 1 (wolframin) |
chr18_+_77155942 | 5.00 |
ENST00000397790.2
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1 |
chr1_+_61548225 | 4.98 |
ENST00000371187.3
|
NFIA
|
nuclear factor I/A |
chr4_+_41362796 | 4.97 |
ENST00000508501.1
ENST00000512946.1 ENST00000313860.7 ENST00000512632.1 ENST00000512820.1 |
LIMCH1
|
LIM and calponin homology domains 1 |
chr12_+_53443680 | 4.91 |
ENST00000314250.6
ENST00000451358.1 |
TENC1
|
tensin like C1 domain containing phosphatase (tensin 2) |
chr9_+_71320557 | 4.83 |
ENST00000541509.1
|
PIP5K1B
|
phosphatidylinositol-4-phosphate 5-kinase, type I, beta |
chr4_+_4861385 | 4.81 |
ENST00000382723.4
|
MSX1
|
msh homeobox 1 |
chr12_+_123319973 | 4.79 |
ENST00000253083.4
|
HIP1R
|
huntingtin interacting protein 1 related |
chr8_+_27491381 | 4.78 |
ENST00000337221.4
|
SCARA3
|
scavenger receptor class A, member 3 |
chr18_+_59992514 | 4.76 |
ENST00000269485.7
|
TNFRSF11A
|
tumor necrosis factor receptor superfamily, member 11a, NFKB activator |
chrX_+_9754461 | 4.76 |
ENST00000380913.3
|
SHROOM2
|
shroom family member 2 |
chr3_+_39851094 | 4.71 |
ENST00000302541.6
|
MYRIP
|
myosin VIIA and Rab interacting protein |
chr5_+_139027877 | 4.61 |
ENST00000302517.3
|
CXXC5
|
CXXC finger protein 5 |
chr1_-_95007193 | 4.54 |
ENST00000370207.4
ENST00000334047.7 |
F3
|
coagulation factor III (thromboplastin, tissue factor) |
chr6_-_150185156 | 4.52 |
ENST00000239367.2
ENST00000367368.2 |
LRP11
|
low density lipoprotein receptor-related protein 11 |
chr9_+_128509663 | 4.52 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr9_-_77703056 | 4.48 |
ENST00000376811.1
|
NMRK1
|
nicotinamide riboside kinase 1 |
chr18_+_77724561 | 4.48 |
ENST00000451882.2
|
HSBP1L1
|
heat shock factor binding protein 1-like 1 |
chr14_-_50999190 | 4.46 |
ENST00000557390.1
|
MAP4K5
|
mitogen-activated protein kinase kinase kinase kinase 5 |
chr16_-_30032610 | 4.46 |
ENST00000574405.1
|
DOC2A
|
double C2-like domains, alpha |
chr1_+_61547894 | 4.44 |
ENST00000403491.3
|
NFIA
|
nuclear factor I/A |
chr8_+_37654693 | 4.42 |
ENST00000412232.2
|
GPR124
|
G protein-coupled receptor 124 |
chr16_+_55542910 | 4.41 |
ENST00000262134.5
|
LPCAT2
|
lysophosphatidylcholine acyltransferase 2 |
chr11_+_59522837 | 4.39 |
ENST00000437946.2
|
STX3
|
syntaxin 3 |
chr1_-_209979465 | 4.36 |
ENST00000542854.1
|
IRF6
|
interferon regulatory factor 6 |
chr10_+_35416090 | 4.32 |
ENST00000354759.3
|
CREM
|
cAMP responsive element modulator |
chr1_+_25943959 | 4.32 |
ENST00000374332.4
|
MAN1C1
|
mannosidase, alpha, class 1C, member 1 |
chr22_+_19744226 | 4.31 |
ENST00000332710.4
ENST00000329705.7 ENST00000359500.3 |
TBX1
|
T-box 1 |
chr1_+_84543734 | 4.29 |
ENST00000370689.2
|
PRKACB
|
protein kinase, cAMP-dependent, catalytic, beta |
chr11_-_33891362 | 4.27 |
ENST00000395833.3
|
LMO2
|
LIM domain only 2 (rhombotin-like 1) |
chr3_+_32147997 | 4.26 |
ENST00000282541.5
|
GPD1L
|
glycerol-3-phosphate dehydrogenase 1-like |
chr17_+_15848231 | 4.24 |
ENST00000304222.2
|
ADORA2B
|
adenosine A2b receptor |
chr7_+_12726474 | 4.23 |
ENST00000396662.1
ENST00000356797.3 ENST00000396664.2 |
ARL4A
|
ADP-ribosylation factor-like 4A |
chr4_+_87928140 | 4.21 |
ENST00000307808.6
|
AFF1
|
AF4/FMR2 family, member 1 |
chr6_-_84418860 | 4.20 |
ENST00000521743.1
|
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr1_-_209979375 | 4.18 |
ENST00000367021.3
|
IRF6
|
interferon regulatory factor 6 |
chr9_-_77703115 | 4.18 |
ENST00000361092.4
ENST00000376808.4 |
NMRK1
|
nicotinamide riboside kinase 1 |
chr10_-_81205373 | 4.17 |
ENST00000372336.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr10_+_35416223 | 4.12 |
ENST00000489321.1
ENST00000427847.2 ENST00000345491.3 ENST00000395895.2 ENST00000374728.3 ENST00000487132.1 |
CREM
|
cAMP responsive element modulator |
chr1_+_61548374 | 4.09 |
ENST00000485903.2
ENST00000371185.2 ENST00000371184.2 |
NFIA
|
nuclear factor I/A |
chr10_+_35415978 | 4.07 |
ENST00000429130.3
ENST00000469949.2 ENST00000460270.1 |
CREM
|
cAMP responsive element modulator |
chr17_+_4402133 | 4.04 |
ENST00000329078.3
|
SPNS2
|
spinster homolog 2 (Drosophila) |
chr16_-_88772761 | 4.04 |
ENST00000567844.1
ENST00000312838.4 |
RNF166
|
ring finger protein 166 |
chr7_+_106685079 | 3.98 |
ENST00000265717.4
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta |
chr17_+_68165657 | 3.98 |
ENST00000243457.3
|
KCNJ2
|
potassium inwardly-rectifying channel, subfamily J, member 2 |
chr20_+_62694461 | 3.97 |
ENST00000343484.5
ENST00000395053.3 |
TCEA2
|
transcription elongation factor A (SII), 2 |
chr6_-_13487784 | 3.93 |
ENST00000379287.3
|
GFOD1
|
glucose-fructose oxidoreductase domain containing 1 |
chr2_+_12857043 | 3.90 |
ENST00000381465.2
|
TRIB2
|
tribbles pseudokinase 2 |
chr17_+_65821636 | 3.89 |
ENST00000544778.2
|
BPTF
|
bromodomain PHD finger transcription factor |
chr6_-_84418841 | 3.88 |
ENST00000369694.2
ENST00000195649.6 |
SNAP91
|
synaptosomal-associated protein, 91kDa |
chr7_+_155090271 | 3.85 |
ENST00000476756.1
|
INSIG1
|
insulin induced gene 1 |
chr2_+_70485220 | 3.82 |
ENST00000433351.2
ENST00000264441.5 |
PCYOX1
|
prenylcysteine oxidase 1 |
chr16_-_49890016 | 3.80 |
ENST00000563137.2
|
ZNF423
|
zinc finger protein 423 |
chr6_-_144329531 | 3.77 |
ENST00000429150.1
ENST00000392309.1 ENST00000416623.1 ENST00000392307.1 |
PLAGL1
|
pleiomorphic adenoma gene-like 1 |
chr3_+_32280159 | 3.76 |
ENST00000458535.2
ENST00000307526.3 |
CMTM8
|
CKLF-like MARVEL transmembrane domain containing 8 |
chr1_+_65886244 | 3.75 |
ENST00000344610.8
|
LEPR
|
leptin receptor |
chr2_-_208489707 | 3.72 |
ENST00000448007.2
ENST00000432416.1 ENST00000411432.1 |
METTL21A
|
methyltransferase like 21A |
chr13_-_44453826 | 3.72 |
ENST00000444614.3
|
CCDC122
|
coiled-coil domain containing 122 |
chr2_-_240322643 | 3.70 |
ENST00000345617.3
|
HDAC4
|
histone deacetylase 4 |
chr10_+_35415719 | 3.69 |
ENST00000474362.1
ENST00000374721.3 |
CREM
|
cAMP responsive element modulator |
chr11_-_119234876 | 3.69 |
ENST00000525735.1
|
USP2
|
ubiquitin specific peptidase 2 |
chr12_+_93965451 | 3.66 |
ENST00000548537.1
|
SOCS2
|
suppressor of cytokine signaling 2 |
chr5_+_68788594 | 3.61 |
ENST00000396442.2
ENST00000380766.2 |
OCLN
|
occludin |
chr2_-_152684977 | 3.60 |
ENST00000428992.2
ENST00000295087.8 |
ARL5A
|
ADP-ribosylation factor-like 5A |
chr8_+_56792377 | 3.60 |
ENST00000520220.2
|
LYN
|
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
chr20_+_62694590 | 3.58 |
ENST00000339217.4
|
TCEA2
|
transcription elongation factor A (SII), 2 |
chr20_-_57582296 | 3.53 |
ENST00000217131.5
|
CTSZ
|
cathepsin Z |
chr8_-_28243934 | 3.53 |
ENST00000521185.1
ENST00000520290.1 ENST00000344423.5 |
ZNF395
|
zinc finger protein 395 |
chr9_-_139581875 | 3.53 |
ENST00000371696.2
|
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr8_+_37654424 | 3.53 |
ENST00000315215.7
|
GPR124
|
G protein-coupled receptor 124 |
chr16_+_640201 | 3.52 |
ENST00000563109.1
|
RAB40C
|
RAB40C, member RAS oncogene family |
chr16_+_30406721 | 3.52 |
ENST00000320159.2
|
ZNF48
|
zinc finger protein 48 |
chr9_+_128509624 | 3.51 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr16_-_30107491 | 3.51 |
ENST00000566134.1
ENST00000565110.1 ENST00000398841.1 ENST00000398838.4 |
YPEL3
|
yippee-like 3 (Drosophila) |
chr20_-_47444420 | 3.51 |
ENST00000371941.3
ENST00000396220.1 |
PREX1
|
phosphatidylinositol-3,4,5-trisphosphate-dependent Rac exchange factor 1 |
chr15_+_57668695 | 3.49 |
ENST00000281282.5
|
CGNL1
|
cingulin-like 1 |
chr5_+_139028510 | 3.49 |
ENST00000502336.1
ENST00000520967.1 ENST00000511048.1 |
CXXC5
|
CXXC finger protein 5 |
chr6_+_130686856 | 3.47 |
ENST00000296978.3
|
TMEM200A
|
transmembrane protein 200A |
chr12_+_93965609 | 3.41 |
ENST00000549887.1
ENST00000551556.1 |
SOCS2
|
suppressor of cytokine signaling 2 |
chr2_+_7057523 | 3.41 |
ENST00000320892.6
|
RNF144A
|
ring finger protein 144A |
chr9_-_139581848 | 3.38 |
ENST00000538402.1
ENST00000371694.3 |
AGPAT2
|
1-acylglycerol-3-phosphate O-acyltransferase 2 |
chr12_+_3186521 | 3.38 |
ENST00000537971.1
ENST00000011898.5 |
TSPAN9
|
tetraspanin 9 |
chr14_+_105992906 | 3.37 |
ENST00000392519.2
|
TMEM121
|
transmembrane protein 121 |
chr15_-_71055769 | 3.37 |
ENST00000539319.1
|
UACA
|
uveal autoantigen with coiled-coil domains and ankyrin repeats |
chr7_-_38670957 | 3.35 |
ENST00000325590.5
ENST00000428293.2 |
AMPH
|
amphiphysin |
chr19_+_11201275 | 3.34 |
ENST00000252444.5
|
LDLR
|
low density lipoprotein receptor |
chr10_-_125851961 | 3.33 |
ENST00000346248.5
|
CHST15
|
carbohydrate (N-acetylgalactosamine 4-sulfate 6-O) sulfotransferase 15 |
chr3_-_148804275 | 3.32 |
ENST00000392912.2
ENST00000465259.1 ENST00000310053.5 ENST00000494055.1 |
HLTF
|
helicase-like transcription factor |
chr16_-_88772670 | 3.32 |
ENST00000562544.1
|
RNF166
|
ring finger protein 166 |
chr16_+_81812863 | 3.31 |
ENST00000359376.3
|
PLCG2
|
phospholipase C, gamma 2 (phosphatidylinositol-specific) |
chr20_+_34742650 | 3.30 |
ENST00000373945.1
ENST00000338074.2 |
EPB41L1
|
erythrocyte membrane protein band 4.1-like 1 |
chr1_+_61547405 | 3.28 |
ENST00000371189.4
|
NFIA
|
nuclear factor I/A |
chr1_+_65210772 | 3.27 |
ENST00000371072.4
ENST00000294428.3 |
RAVER2
|
ribonucleoprotein, PTB-binding 2 |
chr2_+_12857015 | 3.27 |
ENST00000155926.4
|
TRIB2
|
tribbles pseudokinase 2 |
chr17_-_34122596 | 3.27 |
ENST00000250144.8
|
MMP28
|
matrix metallopeptidase 28 |
chr4_-_103682071 | 3.25 |
ENST00000505239.1
|
MANBA
|
mannosidase, beta A, lysosomal |
chr10_+_94608245 | 3.24 |
ENST00000443748.2
ENST00000260762.6 |
EXOC6
|
exocyst complex component 6 |
chr17_+_65821780 | 3.24 |
ENST00000321892.4
ENST00000335221.5 ENST00000306378.6 |
BPTF
|
bromodomain PHD finger transcription factor |
chr19_-_14628645 | 3.24 |
ENST00000598235.1
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr4_+_156587853 | 3.23 |
ENST00000506455.1
ENST00000511108.1 |
GUCY1A3
|
guanylate cyclase 1, soluble, alpha 3 |
chr22_-_37915247 | 3.22 |
ENST00000251973.5
|
CARD10
|
caspase recruitment domain family, member 10 |
chr17_+_40913264 | 3.21 |
ENST00000587142.1
ENST00000588576.1 |
RAMP2
|
receptor (G protein-coupled) activity modifying protein 2 |
chr1_+_210502238 | 3.20 |
ENST00000545154.1
ENST00000537898.1 ENST00000391905.3 ENST00000545781.1 ENST00000261458.3 ENST00000308852.6 |
HHAT
|
hedgehog acyltransferase |
chr19_+_17337406 | 3.20 |
ENST00000597836.1
|
OCEL1
|
occludin/ELL domain containing 1 |
chr17_-_5487768 | 3.17 |
ENST00000269280.4
ENST00000345221.3 ENST00000262467.5 |
NLRP1
|
NLR family, pyrin domain containing 1 |
chr13_-_101327028 | 3.17 |
ENST00000328767.5
ENST00000342624.5 ENST00000376234.3 ENST00000423847.1 |
TMTC4
|
transmembrane and tetratricopeptide repeat containing 4 |
chr6_+_86159765 | 3.15 |
ENST00000369646.3
ENST00000257770.3 |
NT5E
|
5'-nucleotidase, ecto (CD73) |
chr8_-_99129384 | 3.14 |
ENST00000521560.1
ENST00000254878.3 |
HRSP12
|
heat-responsive protein 12 |
chr11_-_63536113 | 3.11 |
ENST00000433688.1
ENST00000546282.2 |
C11orf95
RP11-466C23.4
|
chromosome 11 open reading frame 95 RP11-466C23.4 |
chr4_+_55524085 | 3.11 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chr7_-_38671098 | 3.10 |
ENST00000356264.2
|
AMPH
|
amphiphysin |
chr6_+_84743436 | 3.10 |
ENST00000257776.4
|
MRAP2
|
melanocortin 2 receptor accessory protein 2 |
chr9_+_82188077 | 3.10 |
ENST00000425506.1
|
TLE4
|
transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila) |
chr8_-_99129338 | 3.10 |
ENST00000520507.1
|
HRSP12
|
heat-responsive protein 12 |
chr5_+_52285144 | 3.09 |
ENST00000296585.5
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) |
chr1_+_33722080 | 3.09 |
ENST00000483388.1
ENST00000539719.1 |
ZNF362
|
zinc finger protein 362 |
chrX_+_117861535 | 3.09 |
ENST00000371666.3
ENST00000371642.1 |
IL13RA1
|
interleukin 13 receptor, alpha 1 |
chr6_+_126112074 | 3.06 |
ENST00000453302.1
ENST00000417494.1 ENST00000229634.9 |
NCOA7
|
nuclear receptor coactivator 7 |
chr4_-_149365827 | 3.06 |
ENST00000344721.4
|
NR3C2
|
nuclear receptor subfamily 3, group C, member 2 |
chr14_+_100259666 | 3.06 |
ENST00000262233.6
ENST00000334192.4 |
EML1
|
echinoderm microtubule associated protein like 1 |
chr1_+_78354175 | 3.05 |
ENST00000401035.3
ENST00000457030.1 ENST00000330010.8 |
NEXN
|
nexilin (F actin binding protein) |
chr4_+_144258021 | 3.04 |
ENST00000262994.4
|
GAB1
|
GRB2-associated binding protein 1 |
chr14_-_89883412 | 3.04 |
ENST00000557258.1
|
FOXN3
|
forkhead box N3 |
chr10_+_81466084 | 3.03 |
ENST00000342531.2
|
NUTM2B
|
NUT family member 2B |
chr1_-_59043166 | 3.03 |
ENST00000371225.2
|
TACSTD2
|
tumor-associated calcium signal transducer 2 |
chr6_+_143857949 | 3.03 |
ENST00000367584.4
|
PHACTR2
|
phosphatase and actin regulator 2 |
chr2_-_208489275 | 3.03 |
ENST00000272839.3
ENST00000426075.1 |
METTL21A
|
methyltransferase like 21A |
chr13_-_49107303 | 3.02 |
ENST00000344532.3
|
RCBTB2
|
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
chr7_+_74072288 | 3.02 |
ENST00000443166.1
|
GTF2I
|
general transcription factor IIi |
chr12_+_82752275 | 3.01 |
ENST00000248306.3
|
METTL25
|
methyltransferase like 25 |
chr10_-_126849588 | 3.01 |
ENST00000411419.2
|
CTBP2
|
C-terminal binding protein 2 |
chr18_+_11981547 | 2.98 |
ENST00000588927.1
|
IMPA2
|
inositol(myo)-1(or 4)-monophosphatase 2 |
chr9_+_139971921 | 2.97 |
ENST00000409858.3
|
UAP1L1
|
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1 |
chr6_-_41909191 | 2.96 |
ENST00000512426.1
ENST00000372987.4 |
CCND3
|
cyclin D3 |
chr11_+_64879317 | 2.94 |
ENST00000526809.1
ENST00000279263.7 ENST00000524986.1 ENST00000534371.1 ENST00000540748.1 ENST00000525385.1 ENST00000345348.5 ENST00000531321.1 ENST00000529414.1 ENST00000526085.1 ENST00000530750.1 |
TM7SF2
|
transmembrane 7 superfamily member 2 |
chr13_-_113242439 | 2.93 |
ENST00000375669.3
ENST00000261965.3 |
TUBGCP3
|
tubulin, gamma complex associated protein 3 |
chr16_-_46864955 | 2.93 |
ENST00000565112.1
|
C16orf87
|
chromosome 16 open reading frame 87 |
chr1_+_109102652 | 2.93 |
ENST00000370035.3
ENST00000405454.1 |
FAM102B
|
family with sequence similarity 102, member B |
chr5_-_111093406 | 2.91 |
ENST00000379671.3
|
NREP
|
neuronal regeneration related protein |
chrX_-_125686784 | 2.90 |
ENST00000371126.1
|
DCAF12L1
|
DDB1 and CUL4 associated factor 12-like 1 |
chr7_-_72992865 | 2.90 |
ENST00000452475.1
|
TBL2
|
transducin (beta)-like 2 |
chr8_+_96146168 | 2.88 |
ENST00000519516.1
|
PLEKHF2
|
pleckstrin homology domain containing, family F (with FYVE domain) member 2 |
chr21_-_27945562 | 2.87 |
ENST00000299340.4
ENST00000435845.2 |
CYYR1
|
cysteine/tyrosine-rich 1 |
chr9_+_129089088 | 2.87 |
ENST00000361171.3
ENST00000545391.1 |
MVB12B
|
multivesicular body subunit 12B |
chr9_-_111775772 | 2.85 |
ENST00000325580.6
ENST00000374593.4 ENST00000374595.4 ENST00000325551.4 |
CTNNAL1
|
catenin (cadherin-associated protein), alpha-like 1 |
chr2_-_43453734 | 2.85 |
ENST00000282388.3
|
ZFP36L2
|
ZFP36 ring finger protein-like 2 |
chr6_+_53659746 | 2.85 |
ENST00000370888.1
|
LRRC1
|
leucine rich repeat containing 1 |
chr12_+_27396901 | 2.85 |
ENST00000541191.1
ENST00000389032.3 |
STK38L
|
serine/threonine kinase 38 like |
chr15_-_34659349 | 2.84 |
ENST00000314891.6
|
LPCAT4
|
lysophosphatidylcholine acyltransferase 4 |
chr18_+_20513278 | 2.82 |
ENST00000327155.5
|
RBBP8
|
retinoblastoma binding protein 8 |
chr6_+_86159821 | 2.81 |
ENST00000369651.3
|
NT5E
|
5'-nucleotidase, ecto (CD73) |
chr4_-_89080003 | 2.81 |
ENST00000237612.3
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 |
chr11_-_6341724 | 2.80 |
ENST00000530979.1
|
PRKCDBP
|
protein kinase C, delta binding protein |
chr2_-_101767715 | 2.80 |
ENST00000376840.4
ENST00000409318.1 |
TBC1D8
|
TBC1 domain family, member 8 (with GRAM domain) |
chr22_-_37915535 | 2.77 |
ENST00000403299.1
|
CARD10
|
caspase recruitment domain family, member 10 |
chr19_+_17337473 | 2.76 |
ENST00000598068.1
|
OCEL1
|
occludin/ELL domain containing 1 |
chr8_-_101322132 | 2.76 |
ENST00000523481.1
|
RNF19A
|
ring finger protein 19A, RBR E3 ubiquitin protein ligase |
chr4_+_140586922 | 2.76 |
ENST00000265498.1
ENST00000506797.1 |
MGST2
|
microsomal glutathione S-transferase 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
9.0 | 54.3 | GO:0052565 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
3.8 | 23.0 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
3.8 | 11.3 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
3.1 | 9.4 | GO:0072019 | proximal convoluted tubule development(GO:0072019) metanephric proximal convoluted tubule development(GO:0072229) |
3.0 | 8.9 | GO:0060503 | apoptotic process involved in endocardial cushion morphogenesis(GO:0003277) intermediate mesoderm morphogenesis(GO:0048390) intermediate mesoderm formation(GO:0048391) intermediate mesodermal cell differentiation(GO:0048392) regulation of cardiac muscle fiber development(GO:0055018) positive regulation of cardiac muscle fiber development(GO:0055020) bud dilation involved in lung branching(GO:0060503) BMP signaling pathway involved in ureter morphogenesis(GO:0061149) renal system segmentation(GO:0061150) BMP signaling pathway involved in renal system segmentation(GO:0061151) pulmonary artery endothelial tube morphogenesis(GO:0061155) regulation of transcription from RNA polymerase II promoter involved in mesonephros development(GO:0061216) BMP signaling pathway involved in nephric duct formation(GO:0071893) negative regulation of branch elongation involved in ureteric bud branching(GO:0072096) negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway(GO:0072097) anterior/posterior pattern specification involved in ureteric bud development(GO:0072099) specification of ureteric bud anterior/posterior symmetry(GO:0072100) specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway(GO:0072101) ureter epithelial cell differentiation(GO:0072192) negative regulation of mesenchymal cell proliferation involved in ureter development(GO:0072200) positive regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901964) cardiac jelly development(GO:1905072) regulation of metanephric S-shaped body morphogenesis(GO:2000004) negative regulation of metanephric S-shaped body morphogenesis(GO:2000005) regulation of metanephric comma-shaped body morphogenesis(GO:2000006) negative regulation of metanephric comma-shaped body morphogenesis(GO:2000007) |
2.6 | 10.4 | GO:0048170 | positive regulation of long-term neuronal synaptic plasticity(GO:0048170) |
2.5 | 7.6 | GO:0035284 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
2.4 | 14.2 | GO:0061441 | renal artery morphogenesis(GO:0061441) |
2.0 | 6.1 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
2.0 | 8.0 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) |
2.0 | 9.9 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
1.9 | 5.8 | GO:0060369 | positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
1.9 | 11.2 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
1.7 | 6.9 | GO:2000690 | negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
1.7 | 6.8 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
1.6 | 1.6 | GO:0006296 | nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
1.6 | 6.6 | GO:1904978 | regulation of endosome organization(GO:1904978) |
1.6 | 4.9 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
1.6 | 4.8 | GO:1905205 | positive regulation of connective tissue replacement(GO:1905205) |
1.6 | 11.3 | GO:0098881 | exocytic insertion of neurotransmitter receptor to plasma membrane(GO:0098881) exocytic insertion of neurotransmitter receptor to postsynaptic membrane(GO:0098967) |
1.5 | 4.6 | GO:0006097 | glyoxylate cycle(GO:0006097) |
1.5 | 4.6 | GO:0090427 | activation of meiosis(GO:0090427) |
1.5 | 10.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
1.5 | 6.1 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
1.5 | 4.6 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
1.5 | 4.5 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
1.5 | 4.5 | GO:0007037 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
1.5 | 15.1 | GO:0097350 | neutrophil clearance(GO:0097350) |
1.5 | 1.5 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
1.5 | 5.9 | GO:0015917 | aminophospholipid transport(GO:0015917) |
1.5 | 4.4 | GO:0006844 | acyl carnitine transport(GO:0006844) acyl carnitine transmembrane transport(GO:1902616) |
1.5 | 5.9 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
1.5 | 7.3 | GO:0043387 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
1.4 | 9.9 | GO:0097338 | response to clozapine(GO:0097338) |
1.4 | 4.2 | GO:0014740 | negative regulation of muscle hyperplasia(GO:0014740) |
1.3 | 5.3 | GO:1990535 | neuron projection maintenance(GO:1990535) |
1.3 | 2.6 | GO:1901963 | regulation of cell proliferation involved in outflow tract morphogenesis(GO:1901963) |
1.3 | 5.2 | GO:0031064 | negative regulation of histone deacetylation(GO:0031064) |
1.3 | 5.1 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
1.2 | 6.2 | GO:0014886 | transition between slow and fast fiber(GO:0014886) |
1.2 | 3.7 | GO:0055048 | regulation of spindle elongation(GO:0032887) regulation of mitotic spindle elongation(GO:0032888) anastral spindle assembly(GO:0055048) protein localization to spindle pole body(GO:0071988) regulation of protein localization to spindle pole body(GO:1902363) positive regulation of protein localization to spindle pole body(GO:1902365) positive regulation of mitotic spindle elongation(GO:1902846) |
1.2 | 3.6 | GO:0046709 | IDP metabolic process(GO:0046707) IDP catabolic process(GO:0046709) |
1.2 | 4.8 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
1.2 | 3.6 | GO:1904481 | response to tetrahydrofolate(GO:1904481) cellular response to tetrahydrofolate(GO:1904482) |
1.2 | 3.6 | GO:1903964 | monounsaturated fatty acid metabolic process(GO:1903964) monounsaturated fatty acid biosynthetic process(GO:1903966) |
1.1 | 6.9 | GO:0006083 | acetate metabolic process(GO:0006083) |
1.1 | 5.7 | GO:0019075 | virus maturation(GO:0019075) |
1.1 | 4.3 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
1.1 | 9.6 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
1.1 | 2.1 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
1.0 | 3.1 | GO:0036146 | cellular response to mycotoxin(GO:0036146) |
1.0 | 7.2 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
1.0 | 3.1 | GO:0090341 | negative regulation of secretion of lysosomal enzymes(GO:0090341) |
1.0 | 4.1 | GO:0097360 | chorionic trophoblast cell proliferation(GO:0097360) regulation of chorionic trophoblast cell proliferation(GO:1901382) |
1.0 | 9.0 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
1.0 | 4.0 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
1.0 | 4.9 | GO:0060935 | cardiac fibroblast cell differentiation(GO:0060935) cardiac fibroblast cell development(GO:0060936) epicardium-derived cardiac fibroblast cell differentiation(GO:0060938) epicardium-derived cardiac fibroblast cell development(GO:0060939) |
1.0 | 6.9 | GO:2000795 | negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
1.0 | 4.9 | GO:2001106 | regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
1.0 | 4.9 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
1.0 | 6.8 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
1.0 | 3.9 | GO:0090076 | relaxation of skeletal muscle(GO:0090076) |
1.0 | 2.9 | GO:0033341 | regulation of collagen binding(GO:0033341) |
1.0 | 3.8 | GO:1902462 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
1.0 | 5.7 | GO:0030421 | defecation(GO:0030421) |
1.0 | 1.9 | GO:0032792 | negative regulation of CREB transcription factor activity(GO:0032792) |
0.9 | 2.8 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.9 | 2.8 | GO:0021538 | epithalamus development(GO:0021538) habenula development(GO:0021986) |
0.9 | 3.8 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.9 | 2.8 | GO:0001928 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.9 | 4.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.9 | 9.3 | GO:0015677 | copper ion import(GO:0015677) |
0.9 | 1.8 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.9 | 5.5 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.9 | 0.9 | GO:2000137 | negative regulation of cell proliferation involved in heart morphogenesis(GO:2000137) |
0.9 | 2.7 | GO:0042727 | flavin-containing compound biosynthetic process(GO:0042727) |
0.9 | 4.5 | GO:0055011 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.9 | 3.6 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.9 | 1.8 | GO:1904048 | regulation of spontaneous neurotransmitter secretion(GO:1904048) |
0.9 | 8.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.9 | 4.5 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
0.9 | 2.7 | GO:0042938 | dipeptide transport(GO:0042938) |
0.9 | 0.9 | GO:0060689 | cell differentiation involved in salivary gland development(GO:0060689) |
0.9 | 11.3 | GO:1901725 | regulation of histone deacetylase activity(GO:1901725) |
0.9 | 7.8 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.9 | 4.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.9 | 2.6 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.9 | 4.3 | GO:0051622 | negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.9 | 3.4 | GO:1903445 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
0.9 | 1.7 | GO:0006210 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.9 | 2.6 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
0.9 | 0.9 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
0.9 | 6.8 | GO:0018103 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
0.8 | 0.8 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.8 | 3.4 | GO:2001295 | malonyl-CoA biosynthetic process(GO:2001295) |
0.8 | 0.8 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.8 | 1.6 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.8 | 4.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
0.8 | 9.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 3.3 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.8 | 3.3 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.8 | 2.4 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.8 | 2.4 | GO:0036486 | trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) |
0.8 | 2.4 | GO:2000777 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia(GO:2000777) |
0.8 | 3.2 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
0.8 | 0.8 | GO:0043335 | protein unfolding(GO:0043335) |
0.8 | 3.2 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.8 | 1.6 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
0.8 | 3.2 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.8 | 0.8 | GO:0021569 | rhombomere 3 development(GO:0021569) |
0.8 | 3.2 | GO:0060995 | cell-cell signaling involved in kidney development(GO:0060995) Wnt signaling pathway involved in kidney development(GO:0061289) canonical Wnt signaling pathway involved in metanephric kidney development(GO:0061290) cell-cell signaling involved in metanephros development(GO:0072204) |
0.8 | 0.8 | GO:2000017 | positive regulation of determination of dorsal identity(GO:2000017) |
0.8 | 3.1 | GO:0046725 | negative regulation by virus of viral protein levels in host cell(GO:0046725) negative regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072308) |
0.8 | 7.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.8 | 2.3 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.8 | 0.8 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.8 | 4.6 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.8 | 2.3 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.8 | 3.8 | GO:0072209 | metanephric mesangial cell differentiation(GO:0072209) metanephric glomerular mesangial cell differentiation(GO:0072254) |
0.7 | 4.5 | GO:0070560 | protein secretion by platelet(GO:0070560) |
0.7 | 3.0 | GO:0006218 | uridine catabolic process(GO:0006218) |
0.7 | 2.2 | GO:0070632 | spindle pole body duplication(GO:0030474) spindle pole body organization(GO:0051300) spindle pole body localization(GO:0070631) establishment of spindle pole body localization(GO:0070632) spindle pole body localization to nuclear envelope(GO:0071789) establishment of spindle pole body localization to nuclear envelope(GO:0071790) |
0.7 | 2.2 | GO:0090283 | regulation of protein glycosylation in Golgi(GO:0090283) |
0.7 | 3.0 | GO:0090245 | axis elongation involved in somitogenesis(GO:0090245) |
0.7 | 1.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.7 | 5.0 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.7 | 2.1 | GO:0097187 | dentinogenesis(GO:0097187) |
0.7 | 2.1 | GO:0043105 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.7 | 2.1 | GO:0006272 | leading strand elongation(GO:0006272) |
0.7 | 2.1 | GO:1900276 | regulation of proteinase activated receptor activity(GO:1900276) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.7 | 2.1 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.7 | 2.1 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.7 | 2.1 | GO:1903028 | positive regulation of opsonization(GO:1903028) |
0.7 | 2.8 | GO:0002086 | diaphragm contraction(GO:0002086) |
0.7 | 2.1 | GO:0070839 | divalent metal ion export(GO:0070839) |
0.7 | 2.8 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.7 | 6.8 | GO:1902949 | positive regulation of tau-protein kinase activity(GO:1902949) |
0.7 | 4.1 | GO:0009098 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.7 | 2.7 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.7 | 2.7 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
0.7 | 8.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.7 | 2.0 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.7 | 5.3 | GO:0075071 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.7 | 1.3 | GO:0003150 | muscular septum morphogenesis(GO:0003150) |
0.7 | 2.0 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.7 | 2.0 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.7 | 3.9 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
0.7 | 5.9 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.7 | 1.3 | GO:0033216 | ferric iron import(GO:0033216) |
0.7 | 3.3 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.6 | 1.9 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.6 | 1.9 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.6 | 1.9 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.6 | 7.0 | GO:0014877 | response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.6 | 2.5 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.6 | 6.8 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.6 | 4.9 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.6 | 6.1 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.6 | 3.1 | GO:0050668 | cellular response to phosphate starvation(GO:0016036) positive regulation of sulfur amino acid metabolic process(GO:0031337) positive regulation of homocysteine metabolic process(GO:0050668) |
0.6 | 1.8 | GO:0036509 | trimming of terminal mannose on B branch(GO:0036509) trimming of first mannose on A branch(GO:0036511) trimming of second mannose on A branch(GO:0036512) |
0.6 | 1.8 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.6 | 0.6 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.6 | 1.8 | GO:1900039 | positive regulation of cellular response to hypoxia(GO:1900039) |
0.6 | 2.4 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.6 | 3.0 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.6 | 17.6 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.6 | 13.9 | GO:0072189 | ureter development(GO:0072189) |
0.6 | 1.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.6 | 2.4 | GO:2000544 | cell chemotaxis to fibroblast growth factor(GO:0035766) endothelial cell chemotaxis to fibroblast growth factor(GO:0035768) regulation of cell chemotaxis to fibroblast growth factor(GO:1904847) regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000544) |
0.6 | 12.6 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.6 | 1.2 | GO:0007497 | posterior midgut development(GO:0007497) |
0.6 | 3.0 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.6 | 3.6 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.6 | 3.6 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
0.6 | 1.8 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
0.6 | 4.8 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
0.6 | 1.2 | GO:0071316 | cellular response to nicotine(GO:0071316) |
0.6 | 1.8 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.6 | 2.9 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.6 | 2.3 | GO:2001151 | regulation of renal water transport(GO:2001151) positive regulation of renal water transport(GO:2001153) |
0.6 | 2.9 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.6 | 1.7 | GO:1903464 | negative regulation of mitotic cell cycle DNA replication(GO:1903464) |
0.6 | 0.6 | GO:0090164 | asymmetric Golgi ribbon formation(GO:0090164) |
0.6 | 5.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.6 | 19.0 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.6 | 1.7 | GO:0097252 | oligodendrocyte apoptotic process(GO:0097252) |
0.6 | 3.4 | GO:0032252 | secretory granule localization(GO:0032252) |
0.6 | 1.7 | GO:0046080 | dUTP metabolic process(GO:0046080) dUTP catabolic process(GO:0046081) |
0.6 | 2.3 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.6 | 7.3 | GO:0015074 | DNA integration(GO:0015074) |
0.6 | 6.8 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.6 | 2.8 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.6 | 0.6 | GO:0051664 | nuclear pore distribution(GO:0031081) nuclear pore localization(GO:0051664) |
0.6 | 1.7 | GO:0052151 | positive regulation by symbiont of host apoptotic process(GO:0052151) positive regulation of apoptotic process by virus(GO:0060139) |
0.6 | 1.7 | GO:0048203 | vesicle targeting, trans-Golgi to endosome(GO:0048203) |
0.6 | 2.2 | GO:1904450 | gamma-aminobutyric acid catabolic process(GO:0009450) negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
0.6 | 1.7 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.6 | 1.7 | GO:0051714 | positive regulation of cytolysis in other organism(GO:0051714) |
0.5 | 4.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.5 | 3.3 | GO:0034670 | chemotaxis to arachidonic acid(GO:0034670) response to arachidonic acid(GO:1904550) |
0.5 | 3.3 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 2.2 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.5 | 1.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
0.5 | 2.7 | GO:0071051 | polyadenylation-dependent snoRNA 3'-end processing(GO:0071051) |
0.5 | 0.5 | GO:2001301 | lipoxin biosynthetic process(GO:2001301) lipoxin A4 metabolic process(GO:2001302) lipoxin A4 biosynthetic process(GO:2001303) |
0.5 | 3.7 | GO:0090206 | negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
0.5 | 1.1 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.5 | 1.6 | GO:0042040 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.5 | 1.1 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.5 | 3.7 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.5 | 5.2 | GO:0006983 | ER overload response(GO:0006983) |
0.5 | 6.3 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.5 | 2.1 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) |
0.5 | 1.0 | GO:0006425 | glutaminyl-tRNA aminoacylation(GO:0006425) |
0.5 | 2.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 1.5 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.5 | 12.3 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.5 | 0.5 | GO:0021650 | vestibulocochlear nerve formation(GO:0021650) |
0.5 | 1.5 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.5 | 1.5 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
0.5 | 7.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.5 | 1.5 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) |
0.5 | 2.0 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.5 | 1.0 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.5 | 0.5 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.5 | 2.0 | GO:0006574 | valine catabolic process(GO:0006574) |
0.5 | 5.5 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.5 | 1.5 | GO:2000308 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.5 | 0.5 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.5 | 1.0 | GO:0044332 | Wnt signaling pathway involved in dorsal/ventral axis specification(GO:0044332) |
0.5 | 4.4 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.5 | 5.4 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
0.5 | 6.3 | GO:0045475 | locomotor rhythm(GO:0045475) |
0.5 | 0.5 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.5 | 1.5 | GO:0014876 | response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.5 | 0.5 | GO:0061084 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.5 | 1.5 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.5 | 2.9 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
0.5 | 6.3 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.5 | 1.5 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.5 | 1.9 | GO:0042412 | taurine biosynthetic process(GO:0042412) |
0.5 | 5.8 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.5 | 4.8 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.5 | 4.3 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.5 | 1.4 | GO:0019243 | methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione(GO:0019243) methylglyoxal catabolic process(GO:0051596) methylglyoxal catabolic process to lactate(GO:0061727) |
0.5 | 1.4 | GO:1901202 | negative regulation of extracellular matrix assembly(GO:1901202) |
0.5 | 0.5 | GO:0072003 | kidney rudiment formation(GO:0072003) |
0.5 | 1.9 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.5 | 2.9 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.5 | 1.4 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.5 | 1.9 | GO:0016598 | protein arginylation(GO:0016598) |
0.5 | 1.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.5 | 0.5 | GO:0033591 | response to L-ascorbic acid(GO:0033591) |
0.5 | 3.3 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.5 | 1.4 | GO:0032240 | negative regulation of nucleobase-containing compound transport(GO:0032240) negative regulation of RNA export from nucleus(GO:0046832) |
0.5 | 0.9 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.5 | 0.9 | GO:0010621 | negative regulation of transcription by transcription factor localization(GO:0010621) |
0.5 | 2.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.5 | 13.4 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.5 | 1.4 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.5 | 0.5 | GO:0009405 | pathogenesis(GO:0009405) |
0.5 | 2.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.5 | 0.9 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.5 | 1.8 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.5 | 0.5 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.4 | 0.9 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.4 | 4.5 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
0.4 | 1.3 | GO:0071072 | negative regulation of phospholipid biosynthetic process(GO:0071072) |
0.4 | 2.2 | GO:0097210 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.4 | 8.0 | GO:0016446 | somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.4 | 1.8 | GO:0035752 | lysosomal lumen pH elevation(GO:0035752) |
0.4 | 7.9 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 1.3 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
0.4 | 1.8 | GO:0009956 | radial pattern formation(GO:0009956) |
0.4 | 0.9 | GO:0002572 | pro-T cell differentiation(GO:0002572) |
0.4 | 2.2 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.4 | 0.9 | GO:0032352 | positive regulation of hormone metabolic process(GO:0032352) positive regulation of hormone biosynthetic process(GO:0046886) positive regulation of steroid hormone biosynthetic process(GO:0090031) |
0.4 | 2.6 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.4 | 0.4 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.4 | 5.6 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.4 | 0.4 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.4 | 2.1 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.4 | 0.4 | GO:2000791 | regulation of mesenchymal cell proliferation involved in lung development(GO:2000790) negative regulation of mesenchymal cell proliferation involved in lung development(GO:2000791) |
0.4 | 1.7 | GO:1990502 | dense core granule maturation(GO:1990502) |
0.4 | 4.6 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.4 | 2.5 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.4 | 0.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.4 | 1.7 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.4 | 0.8 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.4 | 1.3 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.4 | 1.2 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.4 | 1.2 | GO:0034059 | response to anoxia(GO:0034059) |
0.4 | 0.8 | GO:0015680 | intracellular copper ion transport(GO:0015680) |
0.4 | 1.2 | GO:0070781 | response to biotin(GO:0070781) |
0.4 | 0.8 | GO:0060490 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.4 | 1.2 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.4 | 2.0 | GO:1904684 | negative regulation of metalloendopeptidase activity(GO:1904684) |
0.4 | 4.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.4 | 1.2 | GO:0097032 | respiratory chain complex II assembly(GO:0034552) mitochondrial respiratory chain complex II assembly(GO:0034553) mitochondrial respiratory chain complex II biogenesis(GO:0097032) |
0.4 | 1.2 | GO:0046416 | D-amino acid metabolic process(GO:0046416) |
0.4 | 2.0 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.4 | 1.2 | GO:2001045 | negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.4 | 2.0 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.4 | 1.2 | GO:1903595 | positive regulation of histamine secretion by mast cell(GO:1903595) |
0.4 | 0.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
0.4 | 1.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.4 | 1.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.4 | 7.1 | GO:0009650 | UV protection(GO:0009650) |
0.4 | 2.4 | GO:0070836 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) caveola assembly(GO:0070836) |
0.4 | 4.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.4 | 0.4 | GO:0070676 | intralumenal vesicle formation(GO:0070676) |
0.4 | 2.0 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.4 | 2.4 | GO:0036111 | very long-chain fatty-acyl-CoA metabolic process(GO:0036111) |
0.4 | 0.8 | GO:0006740 | NADPH regeneration(GO:0006740) |
0.4 | 1.6 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.4 | 1.2 | GO:0035674 | tricarboxylic acid transmembrane transport(GO:0035674) |
0.4 | 4.7 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.4 | 2.3 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.4 | 1.9 | GO:0097384 | cellular lipid biosynthetic process(GO:0097384) |
0.4 | 4.6 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.4 | 1.5 | GO:0033088 | negative regulation of immature T cell proliferation(GO:0033087) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.4 | 3.8 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.4 | 3.4 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.4 | 1.5 | GO:0050976 | sensory perception of touch(GO:0050975) detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
0.4 | 1.1 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
0.4 | 3.4 | GO:0006552 | leucine metabolic process(GO:0006551) leucine catabolic process(GO:0006552) |
0.4 | 2.6 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.4 | 2.2 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.4 | 4.4 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.4 | 1.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
0.4 | 6.6 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.4 | 4.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.4 | 2.2 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.4 | 1.1 | GO:0006267 | pre-replicative complex assembly involved in nuclear cell cycle DNA replication(GO:0006267) pre-replicative complex assembly(GO:0036388) pre-replicative complex assembly involved in cell cycle DNA replication(GO:1902299) |
0.4 | 1.1 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) |
0.4 | 4.4 | GO:0015886 | heme transport(GO:0015886) |
0.4 | 5.1 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.4 | 1.1 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
0.4 | 0.7 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.4 | 0.4 | GO:0021539 | subthalamus development(GO:0021539) |
0.4 | 7.6 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.4 | 4.3 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.4 | 1.1 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.4 | 0.7 | GO:0036363 | transforming growth factor beta activation(GO:0036363) |
0.4 | 3.6 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.4 | 1.1 | GO:1990641 | response to iron ion starvation(GO:1990641) |
0.4 | 3.2 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
0.4 | 1.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.4 | 0.7 | GO:0032679 | TRAIL production(GO:0032639) regulation of TRAIL production(GO:0032679) positive regulation of TRAIL production(GO:0032759) |
0.4 | 2.1 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.4 | 1.4 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.4 | 1.4 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.4 | 0.7 | GO:1905049 | negative regulation of metallopeptidase activity(GO:1905049) |
0.3 | 2.1 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.3 | 7.0 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
0.3 | 2.1 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.3 | 0.7 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
0.3 | 3.1 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) |
0.3 | 4.2 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.3 | 4.2 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.3 | 1.0 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.3 | 1.0 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.3 | 3.1 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.3 | 0.3 | GO:0043000 | Golgi to plasma membrane CFTR protein transport(GO:0043000) |
0.3 | 2.1 | GO:0015853 | adenine transport(GO:0015853) |
0.3 | 1.0 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.3 | 2.0 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.3 | 1.0 | GO:0035494 | SNARE complex disassembly(GO:0035494) |
0.3 | 0.7 | GO:0002384 | hepatic immune response(GO:0002384) |
0.3 | 0.7 | GO:0006404 | RNA import into nucleus(GO:0006404) |
0.3 | 0.7 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.3 | 1.7 | GO:0097327 | response to antineoplastic agent(GO:0097327) |
0.3 | 1.3 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.3 | 0.7 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
0.3 | 1.7 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) |
0.3 | 0.3 | GO:0048239 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.3 | 1.3 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 0.7 | GO:1902728 | positive regulation of skeletal muscle satellite cell proliferation(GO:1902724) positive regulation of growth factor dependent skeletal muscle satellite cell proliferation(GO:1902728) |
0.3 | 3.0 | GO:1904153 | negative regulation of protein exit from endoplasmic reticulum(GO:0070862) negative regulation of retrograde protein transport, ER to cytosol(GO:1904153) |
0.3 | 0.3 | GO:0051582 | positive regulation of neurotransmitter uptake(GO:0051582) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
0.3 | 0.7 | GO:1905123 | regulation of glucosylceramidase activity(GO:1905123) |
0.3 | 0.3 | GO:0010730 | negative regulation of hydrogen peroxide biosynthetic process(GO:0010730) |
0.3 | 0.7 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.3 | 1.0 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
0.3 | 1.0 | GO:1904772 | hepatocyte homeostasis(GO:0036333) response to tetrachloromethane(GO:1904772) |
0.3 | 1.3 | GO:0042560 | folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
0.3 | 0.7 | GO:0010710 | regulation of collagen catabolic process(GO:0010710) |
0.3 | 1.3 | GO:0000103 | sulfate assimilation(GO:0000103) |
0.3 | 2.6 | GO:0060312 | regulation of blood vessel remodeling(GO:0060312) |
0.3 | 1.6 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.3 | 2.3 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.3 | 2.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.3 | 1.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.3 | 0.6 | GO:0006864 | pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
0.3 | 1.9 | GO:0070221 | sulfide oxidation(GO:0019418) sulfide oxidation, using sulfide:quinone oxidoreductase(GO:0070221) |
0.3 | 1.9 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) |
0.3 | 1.0 | GO:0060748 | tertiary branching involved in mammary gland duct morphogenesis(GO:0060748) |
0.3 | 1.3 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) |
0.3 | 1.0 | GO:1900073 | regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
0.3 | 1.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 5.7 | GO:0033540 | fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
0.3 | 3.5 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.3 | 1.0 | GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
0.3 | 4.7 | GO:0001967 | suckling behavior(GO:0001967) |
0.3 | 2.8 | GO:0045176 | apical protein localization(GO:0045176) |
0.3 | 3.5 | GO:0030050 | vesicle transport along actin filament(GO:0030050) |
0.3 | 0.9 | GO:0061582 | intestinal epithelial cell migration(GO:0061582) |
0.3 | 2.2 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
0.3 | 1.3 | GO:0060025 | primary heart field specification(GO:0003138) sinoatrial valve development(GO:0003172) sinoatrial valve morphogenesis(GO:0003185) regulation of synaptic activity(GO:0060025) |
0.3 | 0.9 | GO:0035470 | positive regulation of vascular wound healing(GO:0035470) |
0.3 | 0.6 | GO:0072156 | distal tubule morphogenesis(GO:0072156) |
0.3 | 1.2 | GO:0070901 | mitochondrial tRNA methylation(GO:0070901) |
0.3 | 0.6 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.3 | 0.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.2 | GO:0002024 | diet induced thermogenesis(GO:0002024) |
0.3 | 5.3 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.3 | 1.2 | GO:1990736 | positive regulation of regulation of vascular smooth muscle cell membrane depolarization(GO:1904199) regulation of vascular smooth muscle cell membrane depolarization(GO:1990736) |
0.3 | 0.3 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.3 | 2.2 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.3 | 2.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.3 | 0.3 | GO:1990637 | response to prolactin(GO:1990637) |
0.3 | 2.5 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 3.1 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
0.3 | 5.2 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.3 | 0.6 | GO:0038027 | apolipoprotein A-I-mediated signaling pathway(GO:0038027) |
0.3 | 0.9 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.3 | 1.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 2.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.3 | 1.5 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.3 | 0.3 | GO:0045799 | positive regulation of chromatin assembly or disassembly(GO:0045799) |
0.3 | 0.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.3 | 0.9 | GO:0060179 | male mating behavior(GO:0060179) |
0.3 | 0.9 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 0.6 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.3 | 0.9 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.3 | 0.6 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
0.3 | 13.7 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.3 | 1.8 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
0.3 | 2.4 | GO:0032802 | low-density lipoprotein particle receptor catabolic process(GO:0032802) |
0.3 | 5.1 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
0.3 | 5.4 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.3 | 2.7 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) |
0.3 | 2.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.3 | 2.1 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 1.8 | GO:0035965 | cardiolipin acyl-chain remodeling(GO:0035965) |
0.3 | 0.3 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
0.3 | 4.4 | GO:0031643 | positive regulation of myelination(GO:0031643) |
0.3 | 1.7 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.3 | 0.9 | GO:0023016 | signal transduction by trans-phosphorylation(GO:0023016) |
0.3 | 0.3 | GO:0036510 | trimming of terminal mannose on C branch(GO:0036510) |
0.3 | 0.9 | GO:0033364 | mast cell secretory granule organization(GO:0033364) |
0.3 | 2.9 | GO:1900364 | negative regulation of mRNA polyadenylation(GO:1900364) |
0.3 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.3 | 3.7 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.3 | 2.3 | GO:0072178 | nephric duct morphogenesis(GO:0072178) |
0.3 | 0.3 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.3 | 4.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.3 | 1.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.3 | 2.0 | GO:1904044 | response to aldosterone(GO:1904044) |
0.3 | 0.8 | GO:2000820 | negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
0.3 | 0.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.3 | 1.4 | GO:0015862 | uridine transport(GO:0015862) |
0.3 | 0.3 | GO:0060406 | positive regulation of penile erection(GO:0060406) |
0.3 | 4.8 | GO:0035518 | histone H2A monoubiquitination(GO:0035518) |
0.3 | 0.8 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.3 | 2.5 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 1.1 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.3 | 1.4 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.3 | 1.6 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 0.5 | GO:0002302 | CD8-positive, alpha-beta T cell differentiation involved in immune response(GO:0002302) |
0.3 | 1.1 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.3 | 0.8 | GO:1903778 | protein localization to vacuolar membrane(GO:1903778) |
0.3 | 2.7 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.4 | GO:0033383 | geranyl diphosphate metabolic process(GO:0033383) geranyl diphosphate biosynthetic process(GO:0033384) farnesyl diphosphate biosynthetic process(GO:0045337) |
0.3 | 2.2 | GO:0070875 | positive regulation of glycogen metabolic process(GO:0070875) |
0.3 | 1.4 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
0.3 | 0.3 | GO:0071469 | cellular response to alkaline pH(GO:0071469) |
0.3 | 0.8 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.3 | 2.7 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 0.5 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.1 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.3 | 3.8 | GO:0044794 | positive regulation by host of viral process(GO:0044794) |
0.3 | 0.3 | GO:0090345 | cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
0.3 | 0.3 | GO:0061141 | lung ciliated cell differentiation(GO:0061141) |
0.3 | 2.7 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.3 | 1.3 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 3.2 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.3 | 0.3 | GO:0070602 | regulation of centromeric sister chromatid cohesion(GO:0070602) |
0.3 | 0.8 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.3 | 0.8 | GO:0090675 | intermicrovillar adhesion(GO:0090675) |
0.3 | 0.5 | GO:0009236 | cobalamin biosynthetic process(GO:0009236) |
0.3 | 3.2 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.3 | 1.3 | GO:0001923 | B-1 B cell differentiation(GO:0001923) |
0.3 | 1.1 | GO:0009447 | putrescine catabolic process(GO:0009447) |
0.3 | 1.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 0.8 | GO:0045080 | positive regulation of chemokine biosynthetic process(GO:0045080) |
0.3 | 1.1 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.3 | 0.8 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.3 | 1.3 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.3 | 0.3 | GO:0061010 | gall bladder development(GO:0061010) |
0.3 | 0.5 | GO:0061187 | regulation of chromatin silencing at rDNA(GO:0061187) |
0.3 | 1.6 | GO:1903385 | regulation of homophilic cell adhesion(GO:1903385) |
0.3 | 2.6 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.3 | 0.3 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.3 | 2.6 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.3 | 4.9 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.3 | 13.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.3 | 6.9 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.3 | 1.5 | GO:1904628 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.3 | 0.8 | GO:0071677 | positive regulation of mononuclear cell migration(GO:0071677) |
0.3 | 0.5 | GO:1990834 | response to odorant(GO:1990834) |
0.3 | 2.5 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
0.3 | 0.3 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.3 | 0.3 | GO:0045976 | negative regulation of mitotic cell cycle, embryonic(GO:0045976) |
0.3 | 1.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.3 | 0.5 | GO:0046222 | mycotoxin metabolic process(GO:0043385) aflatoxin metabolic process(GO:0046222) organic heteropentacyclic compound metabolic process(GO:1901376) |
0.3 | 0.5 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.2 | GO:0097491 | sympathetic neuron projection extension(GO:0097490) sympathetic neuron projection guidance(GO:0097491) |
0.2 | 1.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.2 | 0.7 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.2 | 3.9 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.2 | 1.7 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 1.2 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 3.0 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 11.8 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.2 | 0.5 | GO:0050720 | interleukin-1 beta biosynthetic process(GO:0050720) |
0.2 | 0.7 | GO:0070541 | response to platinum ion(GO:0070541) |
0.2 | 6.0 | GO:0070911 | global genome nucleotide-excision repair(GO:0070911) |
0.2 | 1.9 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.2 | 0.5 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.2 | 0.7 | GO:0046338 | phosphatidylethanolamine catabolic process(GO:0046338) |
0.2 | 1.0 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.2 | 5.8 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.2 | 1.2 | GO:0072249 | metanephric glomerular epithelium development(GO:0072244) metanephric glomerular visceral epithelial cell differentiation(GO:0072248) metanephric glomerular visceral epithelial cell development(GO:0072249) metanephric glomerular epithelial cell differentiation(GO:0072312) metanephric glomerular epithelial cell development(GO:0072313) |
0.2 | 1.9 | GO:0015871 | choline transport(GO:0015871) |
0.2 | 0.5 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.2 | 5.0 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.2 | 2.1 | GO:0051418 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.9 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.2 | 1.4 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.2 | 1.4 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 2.3 | GO:1903943 | regulation of hepatocyte apoptotic process(GO:1903943) negative regulation of hepatocyte apoptotic process(GO:1903944) |
0.2 | 1.6 | GO:0090042 | tubulin deacetylation(GO:0090042) |
0.2 | 0.7 | GO:0031247 | actin rod assembly(GO:0031247) |
0.2 | 0.5 | GO:0070428 | regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) |
0.2 | 0.7 | GO:0051036 | regulation of endosome size(GO:0051036) |
0.2 | 1.6 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.2 | 1.6 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.2 | 0.9 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.2 | 0.9 | GO:0030242 | pexophagy(GO:0030242) |
0.2 | 0.9 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.2 | 1.6 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.2 | 0.4 | GO:0035937 | estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
0.2 | 1.6 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
0.2 | 0.9 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
0.2 | 1.6 | GO:0071372 | cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
0.2 | 1.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.2 | 0.9 | GO:0072367 | regulation of lipid transport by regulation of transcription from RNA polymerase II promoter(GO:0072367) |
0.2 | 1.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
0.2 | 4.5 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.2 | 0.4 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
0.2 | 1.1 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.2 | 0.4 | GO:0009441 | glycolate metabolic process(GO:0009441) detoxification of mercury ion(GO:0050787) regulation of fibril organization(GO:1902903) |
0.2 | 0.9 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.2 | 0.4 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.2 | 1.3 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.2 | 0.7 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
0.2 | 0.4 | GO:0071726 | toll-like receptor TLR6:TLR2 signaling pathway(GO:0038124) response to diacyl bacterial lipopeptide(GO:0071724) cellular response to diacyl bacterial lipopeptide(GO:0071726) |
0.2 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 2.0 | GO:0036119 | response to platelet-derived growth factor(GO:0036119) |
0.2 | 2.0 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.2 | 0.9 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 0.6 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.2 | 1.9 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.2 | 2.6 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.2 | 0.6 | GO:0031959 | mineralocorticoid receptor signaling pathway(GO:0031959) |
0.2 | 2.3 | GO:0009437 | carnitine metabolic process(GO:0009437) |
0.2 | 1.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.4 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.2 | 8.5 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
0.2 | 1.9 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.2 | 7.2 | GO:0006517 | protein deglycosylation(GO:0006517) |
0.2 | 1.9 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 1.7 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.2 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
0.2 | 0.8 | GO:0036518 | chemorepulsion of dopaminergic neuron axon(GO:0036518) |
0.2 | 1.0 | GO:0035063 | nuclear speck organization(GO:0035063) |
0.2 | 1.0 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.2 | 0.6 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
0.2 | 4.5 | GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
0.2 | 0.8 | GO:0006064 | glucuronate catabolic process(GO:0006064) glucuronate catabolic process to xylulose 5-phosphate(GO:0019640) xylulose 5-phosphate metabolic process(GO:0051167) xylulose 5-phosphate biosynthetic process(GO:1901159) |
0.2 | 4.2 | GO:0006490 | oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.2 | 0.8 | GO:0032700 | negative regulation of interleukin-17 production(GO:0032700) |
0.2 | 0.4 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.2 | 0.2 | GO:0072720 | response to dithiothreitol(GO:0072720) |
0.2 | 2.6 | GO:0090385 | phagosome-lysosome fusion(GO:0090385) |
0.2 | 1.8 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.2 | 1.2 | GO:0006562 | proline catabolic process(GO:0006562) proline catabolic process to glutamate(GO:0010133) |
0.2 | 0.6 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.2 | 1.2 | GO:0045079 | negative regulation of chemokine biosynthetic process(GO:0045079) |
0.2 | 2.2 | GO:0030091 | protein repair(GO:0030091) |
0.2 | 2.0 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.2 | 0.8 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.2 | 1.2 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.4 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.2 | 0.2 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 0.8 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.2 | 0.6 | GO:0036344 | platelet morphogenesis(GO:0036344) |
0.2 | 1.3 | GO:0021817 | nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration(GO:0021817) nuclear migration along microtubule(GO:0030473) |
0.2 | 0.4 | GO:0061082 | myeloid leukocyte cytokine production(GO:0061082) |
0.2 | 2.1 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.2 | 1.0 | GO:2000312 | regulation of kainate selective glutamate receptor activity(GO:2000312) |
0.2 | 16.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 1.5 | GO:0032049 | cardiolipin biosynthetic process(GO:0032049) |
0.2 | 0.7 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.2 | 0.7 | GO:0060133 | somatotropin secreting cell development(GO:0060133) |
0.2 | 0.4 | GO:0033484 | nitric oxide homeostasis(GO:0033484) |
0.2 | 0.6 | GO:1901253 | negative regulation of intracellular transport of viral material(GO:1901253) |
0.2 | 0.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
0.2 | 0.4 | GO:0000189 | MAPK import into nucleus(GO:0000189) |
0.2 | 0.4 | GO:0071557 | histone H3-K27 demethylation(GO:0071557) |
0.2 | 0.7 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 2.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.2 | 2.8 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 0.6 | GO:1902951 | negative regulation of dendritic spine maintenance(GO:1902951) |
0.2 | 2.6 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.2 | 1.1 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 0.4 | GO:0060717 | chorion development(GO:0060717) |
0.2 | 0.2 | GO:1902473 | regulation of protein localization to synapse(GO:1902473) positive regulation of protein localization to synapse(GO:1902474) |
0.2 | 0.2 | GO:0007509 | mesoderm migration involved in gastrulation(GO:0007509) |
0.2 | 0.7 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.2 | 3.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.2 | 1.5 | GO:0032509 | endosome transport via multivesicular body sorting pathway(GO:0032509) |
0.2 | 0.4 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.2 | 0.5 | GO:0097195 | pilomotor reflex(GO:0097195) |
0.2 | 1.6 | GO:0002191 | cap-dependent translational initiation(GO:0002191) |
0.2 | 1.1 | GO:0072675 | multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
0.2 | 3.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.2 | 0.7 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
0.2 | 0.5 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.2 | 0.9 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.2 | 1.2 | GO:1901142 | insulin metabolic process(GO:1901142) |
0.2 | 0.5 | GO:0021586 | pons maturation(GO:0021586) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.2 | 1.2 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.2 | 3.7 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 1.7 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.2 | 0.7 | GO:0052405 | negative regulation by host of symbiont molecular function(GO:0052405) |
0.2 | 1.9 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) |
0.2 | 0.2 | GO:0010157 | response to chlorate(GO:0010157) |
0.2 | 1.7 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
0.2 | 0.7 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.2 | 0.2 | GO:1903772 | regulation of viral budding via host ESCRT complex(GO:1903772) |
0.2 | 0.2 | GO:1902523 | positive regulation of protein K63-linked ubiquitination(GO:1902523) |
0.2 | 0.5 | GO:0044805 | late nucleophagy(GO:0044805) |
0.2 | 0.2 | GO:0046898 | response to cycloheximide(GO:0046898) |
0.2 | 2.4 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.2 | 3.2 | GO:0045332 | phospholipid translocation(GO:0045332) |
0.2 | 0.2 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.2 | 1.9 | GO:0032025 | response to cobalt ion(GO:0032025) |
0.2 | 4.4 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.2 | GO:1905206 | positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.2 | 0.2 | GO:0043380 | regulation of memory T cell differentiation(GO:0043380) |
0.2 | 0.5 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.2 | 6.9 | GO:0042407 | cristae formation(GO:0042407) |
0.2 | 0.7 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.2 | 9.6 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.2 | 2.2 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
0.2 | 3.8 | GO:1902653 | secondary alcohol biosynthetic process(GO:1902653) |
0.2 | 0.8 | GO:0060065 | uterus development(GO:0060065) |
0.2 | 0.2 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.2 | 2.6 | GO:0060044 | negative regulation of cardiac muscle cell proliferation(GO:0060044) |
0.2 | 0.5 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.5 | GO:1905146 | lysosomal protein catabolic process(GO:1905146) |
0.2 | 0.5 | GO:1902490 | regulation of sperm capacitation(GO:1902490) |
0.2 | 3.3 | GO:0006337 | nucleosome disassembly(GO:0006337) |
0.2 | 0.3 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.2 | 0.5 | GO:1900153 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.2 | 11.7 | GO:1902400 | signal transduction involved in mitotic G1 DNA damage checkpoint(GO:0072431) intracellular signal transduction involved in G1 DNA damage checkpoint(GO:1902400) |
0.2 | 1.3 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 1.5 | GO:0070574 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.2 | 1.0 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.2 | 2.6 | GO:0000338 | protein deneddylation(GO:0000338) |
0.2 | 0.8 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.2 | 2.6 | GO:0070987 | error-free translesion synthesis(GO:0070987) |
0.2 | 0.2 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.2 | 0.8 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.2 | 0.2 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 0.5 | GO:1902824 | positive regulation of late endosome to lysosome transport(GO:1902824) |
0.2 | 2.7 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.2 | 1.3 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 0.5 | GO:0006500 | N-terminal protein palmitoylation(GO:0006500) |
0.2 | 0.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.2 | 0.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.2 | 0.2 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.2 | 0.8 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.2 | 1.9 | GO:0030422 | production of siRNA involved in RNA interference(GO:0030422) |
0.2 | 0.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.2 | 0.9 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.2 | 0.2 | GO:1903416 | response to glycoside(GO:1903416) |
0.2 | 1.7 | GO:0007000 | nucleolus organization(GO:0007000) |
0.2 | 3.4 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.2 | 1.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.2 | 0.6 | GO:0003409 | optic cup structural organization(GO:0003409) |
0.2 | 6.8 | GO:1904837 | beta-catenin-TCF complex assembly(GO:1904837) |
0.2 | 5.4 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.2 | 1.5 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 1.1 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 1.4 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.2 | 0.8 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.2 | 0.6 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.2 | 0.6 | GO:0035635 | entry of bacterium into host cell(GO:0035635) |
0.2 | 0.5 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.2 | 0.3 | GO:0046021 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) |
0.2 | 0.3 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 0.6 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 0.7 | GO:1900425 | negative regulation of defense response to bacterium(GO:1900425) |
0.1 | 0.3 | GO:1905245 | regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902959) regulation of aspartic-type peptidase activity(GO:1905245) |
0.1 | 0.1 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.1 | 0.4 | GO:1901053 | sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
0.1 | 0.6 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.4 | GO:0006121 | mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
0.1 | 0.3 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.1 | 1.3 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
0.1 | 0.6 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
0.1 | 0.9 | GO:1901661 | quinone metabolic process(GO:1901661) |
0.1 | 0.4 | GO:0070370 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.7 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.1 | 0.4 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 0.4 | GO:0097026 | dendritic cell dendrite assembly(GO:0097026) |
0.1 | 0.3 | GO:0051533 | positive regulation of NFAT protein import into nucleus(GO:0051533) |
0.1 | 1.9 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.1 | 1.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 3.0 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 6.8 | GO:2000134 | negative regulation of G1/S transition of mitotic cell cycle(GO:2000134) |
0.1 | 0.6 | GO:0034959 | neuropeptide catabolic process(GO:0010813) substance P catabolic process(GO:0010814) calcitonin catabolic process(GO:0010816) endothelin maturation(GO:0034959) |
0.1 | 0.3 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
0.1 | 1.0 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.7 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.6 | GO:0036116 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.1 | 0.3 | GO:1901339 | regulation of store-operated calcium channel activity(GO:1901339) |
0.1 | 3.0 | GO:0097009 | energy homeostasis(GO:0097009) |
0.1 | 2.4 | GO:0048026 | positive regulation of mRNA splicing, via spliceosome(GO:0048026) |
0.1 | 2.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.1 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.1 | 0.3 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.1 | 0.8 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.1 | 0.3 | GO:0035927 | RNA import into mitochondrion(GO:0035927) |
0.1 | 1.3 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 2.1 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
0.1 | 1.1 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
0.1 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.1 | 2.5 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.1 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 1.3 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.4 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
0.1 | 0.1 | GO:0043987 | histone H3-S10 phosphorylation(GO:0043987) |
0.1 | 0.1 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.1 | 0.3 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.1 | 3.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.1 | 1.1 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) |
0.1 | 0.1 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
0.1 | 1.1 | GO:0051775 | response to redox state(GO:0051775) |
0.1 | 0.5 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.1 | GO:1904386 | response to thyroxine(GO:0097068) response to L-phenylalanine derivative(GO:1904386) |
0.1 | 0.8 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.1 | 0.5 | GO:0021691 | cerebellar Purkinje cell layer maturation(GO:0021691) |
0.1 | 0.4 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 0.9 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.3 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.1 | 0.7 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 1.3 | GO:0017187 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.1 | 0.6 | GO:0001757 | somite specification(GO:0001757) |
0.1 | 1.2 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.1 | 0.4 | GO:0051086 | chaperone mediated protein folding independent of cofactor(GO:0051086) |
0.1 | 0.1 | GO:0046005 | positive regulation of circadian sleep/wake cycle, REM sleep(GO:0046005) |
0.1 | 3.6 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.1 | 0.5 | GO:1990262 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.1 | 0.1 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
0.1 | 0.4 | GO:0072182 | regulation of nephron tubule epithelial cell differentiation(GO:0072182) |
0.1 | 0.4 | GO:1902774 | late endosome to lysosome transport(GO:1902774) |
0.1 | 0.6 | GO:0060154 | cellular process regulating host cell cycle in response to virus(GO:0060154) |
0.1 | 2.1 | GO:0031114 | negative regulation of microtubule depolymerization(GO:0007026) regulation of microtubule depolymerization(GO:0031114) |
0.1 | 0.4 | GO:2000417 | negative regulation of eosinophil migration(GO:2000417) |
0.1 | 0.3 | GO:1902075 | cellular response to salt(GO:1902075) |
0.1 | 0.1 | GO:1904815 | negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
0.1 | 0.6 | GO:0061042 | vascular wound healing(GO:0061042) |
0.1 | 0.2 | GO:0010996 | response to auditory stimulus(GO:0010996) |
0.1 | 0.6 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.1 | 0.5 | GO:0097021 | lymphocyte migration into lymphoid organs(GO:0097021) |
0.1 | 0.5 | GO:0034378 | chylomicron assembly(GO:0034378) |
0.1 | 0.6 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
0.1 | 0.4 | GO:0051958 | methotrexate transport(GO:0051958) reduced folate transmembrane transport(GO:0098838) |
0.1 | 1.2 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.1 | 1.0 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
0.1 | 0.2 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.1 | 0.4 | GO:0000354 | cis assembly of pre-catalytic spliceosome(GO:0000354) |
0.1 | 0.4 | GO:1902255 | positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator(GO:1902255) |
0.1 | 0.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.1 | 0.5 | GO:0046452 | dihydrofolate metabolic process(GO:0046452) |
0.1 | 2.7 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.2 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.1 | 0.4 | GO:0015993 | molecular hydrogen transport(GO:0015993) |
0.1 | 2.4 | GO:0018345 | protein palmitoylation(GO:0018345) |
0.1 | 1.4 | GO:1901407 | regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
0.1 | 2.8 | GO:0090083 | regulation of inclusion body assembly(GO:0090083) |
0.1 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.8 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.8 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
0.1 | 0.1 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.1 | 1.1 | GO:0033005 | positive regulation of mast cell activation(GO:0033005) |
0.1 | 1.8 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.1 | 0.8 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.1 | 0.8 | GO:0071880 | adenylate cyclase-activating adrenergic receptor signaling pathway(GO:0071880) |
0.1 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.1 | 1.4 | GO:1904263 | positive regulation of TORC1 signaling(GO:1904263) |
0.1 | 2.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
0.1 | 1.6 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 1.0 | GO:0060576 | intestinal epithelial cell development(GO:0060576) |
0.1 | 0.6 | GO:0070829 | response to vitamin B2(GO:0033274) heterochromatin maintenance(GO:0070829) |
0.1 | 0.8 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 0.3 | GO:0009120 | deoxyribonucleoside metabolic process(GO:0009120) |
0.1 | 3.5 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
0.1 | 0.1 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
0.1 | 0.1 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.1 | 0.3 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.1 | 0.1 | GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development(GO:0061051) |
0.1 | 3.4 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.4 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.1 | 0.4 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.1 | 0.1 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 0.6 | GO:1904977 | lymphatic endothelial cell migration(GO:1904977) |
0.1 | 0.2 | GO:0060545 | positive regulation of necroptotic process(GO:0060545) |
0.1 | 0.8 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.1 | 0.9 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
0.1 | 1.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 0.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.1 | 0.3 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.3 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.1 | 0.9 | GO:0019323 | pentose catabolic process(GO:0019323) |
0.1 | 0.7 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.1 | 0.8 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
0.1 | 0.8 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.1 | 4.9 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.1 | 0.3 | GO:0042976 | activation of Janus kinase activity(GO:0042976) |
0.1 | 1.3 | GO:0098719 | sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.1 | 0.3 | GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045716) |
0.1 | 0.5 | GO:0051597 | response to methylmercury(GO:0051597) |
0.1 | 1.1 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.3 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.1 | 0.8 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.3 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 2.8 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.4 | GO:0050653 | chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0050653) |
0.1 | 1.2 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.1 | 0.3 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.5 | GO:0010755 | regulation of plasminogen activation(GO:0010755) |
0.1 | 1.0 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.1 | 1.5 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.1 | 0.1 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.1 | 0.4 | GO:0005985 | sucrose metabolic process(GO:0005985) |
0.1 | 2.3 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.1 | 0.8 | GO:0051895 | negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
0.1 | 0.1 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.3 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.1 | 0.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.3 | GO:0060591 | chondroblast differentiation(GO:0060591) |
0.1 | 1.9 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
0.1 | 1.1 | GO:0006069 | ethanol oxidation(GO:0006069) |
0.1 | 0.4 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 1.1 | GO:0033120 | positive regulation of RNA splicing(GO:0033120) |
0.1 | 0.8 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.1 | 0.2 | GO:0043243 | positive regulation of protein complex disassembly(GO:0043243) |
0.1 | 0.9 | GO:2001135 | regulation of endocytic recycling(GO:2001135) |
0.1 | 5.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 0.3 | GO:0034197 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
0.1 | 0.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.1 | 1.0 | GO:0021930 | cell proliferation in external granule layer(GO:0021924) cerebellar granule cell precursor proliferation(GO:0021930) |
0.1 | 0.1 | GO:1904884 | telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
0.1 | 0.3 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.5 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.2 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.1 | 0.9 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.1 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 3.0 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.1 | 1.4 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
0.1 | 0.4 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.3 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 2.0 | GO:0032012 | regulation of ARF protein signal transduction(GO:0032012) |
0.1 | 2.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.1 | 0.3 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.1 | 0.1 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 0.2 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 0.2 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.1 | 1.7 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.2 | GO:0009732 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.1 | 0.6 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 0.2 | GO:0002232 | leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
0.1 | 0.5 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.1 | 0.1 | GO:0098905 | regulation of bundle of His cell action potential(GO:0098905) |
0.1 | 0.7 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.7 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.1 | 0.7 | GO:0000019 | regulation of mitotic recombination(GO:0000019) |
0.1 | 0.5 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.1 | GO:0010728 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) regulation of hydrogen peroxide biosynthetic process(GO:0010728) |
0.1 | 0.4 | GO:1904647 | response to rotenone(GO:1904647) |
0.1 | 0.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.1 | 0.1 | GO:0003419 | growth plate cartilage chondrocyte proliferation(GO:0003419) |
0.1 | 0.6 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.1 | GO:0045829 | negative regulation of isotype switching(GO:0045829) negative regulation of isotype switching to IgE isotypes(GO:0048294) |
0.1 | 1.0 | GO:0035970 | peptidyl-threonine dephosphorylation(GO:0035970) |
0.1 | 0.5 | GO:0031293 | membrane protein intracellular domain proteolysis(GO:0031293) |
0.1 | 0.1 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.1 | 0.5 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.1 | 1.2 | GO:0097066 | response to thyroid hormone(GO:0097066) |
0.1 | 0.1 | GO:2000078 | columnar/cuboidal epithelial cell maturation(GO:0002069) glandular epithelial cell maturation(GO:0002071) type B pancreatic cell maturation(GO:0072560) positive regulation of type B pancreatic cell development(GO:2000078) |
0.1 | 0.1 | GO:0001878 | response to yeast(GO:0001878) |
0.1 | 0.8 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.4 | GO:0060412 | ventricular septum morphogenesis(GO:0060412) |
0.1 | 0.3 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.1 | 1.2 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.5 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.3 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.1 | 0.3 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.1 | 0.5 | GO:0090116 | C-5 methylation of cytosine(GO:0090116) |
0.1 | 1.0 | GO:0070986 | left/right axis specification(GO:0070986) |
0.1 | 0.4 | GO:0032471 | negative regulation of endoplasmic reticulum calcium ion concentration(GO:0032471) |
0.1 | 0.2 | GO:0051461 | regulation of corticotropin secretion(GO:0051459) positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.5 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 0.1 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.1 | 0.1 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.1 | 0.1 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.1 | 0.6 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
0.1 | 0.4 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.5 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 0.3 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.1 | 0.1 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.1 | 0.3 | GO:0010954 | positive regulation of protein processing(GO:0010954) |
0.1 | 0.3 | GO:0048496 | maintenance of organ identity(GO:0048496) |
0.1 | 0.5 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.1 | 0.5 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.2 | GO:0030643 | cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.1 | 0.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.1 | 0.5 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
0.1 | 0.2 | GO:0001575 | globoside metabolic process(GO:0001575) |
0.1 | 0.4 | GO:0038169 | somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
0.1 | 0.2 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.1 | 0.6 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 3.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 1.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.1 | 0.5 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.2 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.6 | GO:0008206 | bile acid metabolic process(GO:0008206) |
0.1 | 0.6 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.1 | 0.8 | GO:0034453 | microtubule anchoring(GO:0034453) |
0.1 | 0.1 | GO:0060214 | endocardium formation(GO:0060214) |
0.1 | 0.5 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.1 | 2.7 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.2 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.1 | 0.3 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.1 | 0.3 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) |
0.1 | 0.1 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.1 | 0.2 | GO:0035815 | positive regulation of renal sodium excretion(GO:0035815) |
0.1 | 0.2 | GO:0044313 | protein K6-linked deubiquitination(GO:0044313) |
0.1 | 2.7 | GO:0051893 | regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
0.1 | 2.1 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.1 | GO:1905065 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 0.5 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.1 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.1 | 1.8 | GO:0009395 | phospholipid catabolic process(GO:0009395) |
0.1 | 0.2 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) |
0.1 | 0.1 | GO:1905244 | regulation of modification of synaptic structure(GO:1905244) |
0.1 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.1 | 0.6 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 0.6 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 0.6 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.1 | 1.0 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.1 | 0.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.6 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.1 | 0.1 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 2.2 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
0.1 | 0.2 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.1 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.6 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0035886 | vascular smooth muscle cell differentiation(GO:0035886) |
0.1 | 1.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.2 | GO:0002818 | intracellular defense response(GO:0002818) |
0.1 | 0.2 | GO:0019520 | aldonic acid metabolic process(GO:0019520) D-gluconate metabolic process(GO:0019521) |
0.1 | 0.8 | GO:0097205 | renal filtration(GO:0097205) |
0.1 | 1.8 | GO:0046710 | GDP metabolic process(GO:0046710) |
0.1 | 0.7 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.2 | GO:0030300 | negative regulation of intestinal phytosterol absorption(GO:0010949) regulation of intestinal cholesterol absorption(GO:0030300) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal absorption(GO:1904479) regulation of intestinal lipid absorption(GO:1904729) negative regulation of intestinal lipid absorption(GO:1904730) |
0.1 | 0.4 | GO:0061744 | motor behavior(GO:0061744) |
0.1 | 0.3 | GO:0046078 | pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
0.1 | 0.2 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.1 | 0.3 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.1 | 0.5 | GO:0045048 | protein insertion into ER membrane(GO:0045048) |
0.1 | 0.2 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 2.1 | GO:0035329 | hippo signaling(GO:0035329) |
0.1 | 0.9 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.1 | 9.7 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.3 | GO:0071386 | cellular response to corticosterone stimulus(GO:0071386) |
0.1 | 0.4 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 1.1 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.2 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
0.1 | 0.2 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.1 | 0.1 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
0.1 | 0.9 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.7 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
0.1 | 0.6 | GO:0009642 | response to light intensity(GO:0009642) |
0.1 | 6.8 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.1 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.1 | 0.1 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.1 | 0.1 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.1 | 0.3 | GO:0030238 | male sex determination(GO:0030238) |
0.1 | 0.1 | GO:0036292 | DNA rewinding(GO:0036292) |
0.1 | 0.3 | GO:0051715 | cytolysis in other organism(GO:0051715) |
0.1 | 0.3 | GO:0042262 | DNA protection(GO:0042262) |
0.1 | 0.1 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.1 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.1 | 0.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.1 | 0.1 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.1 | 1.0 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.2 | GO:1902544 | regulation of DNA N-glycosylase activity(GO:1902544) |
0.1 | 0.5 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.1 | 0.3 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.1 | 0.5 | GO:0010569 | regulation of double-strand break repair via homologous recombination(GO:0010569) |
0.1 | 0.4 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.1 | 0.4 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.5 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.1 | 0.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.4 | GO:0000730 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.1 | GO:0098758 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.1 | 0.1 | GO:0048205 | COPI-coated vesicle budding(GO:0035964) Golgi transport vesicle coating(GO:0048200) COPI coating of Golgi vesicle(GO:0048205) |
0.1 | 0.1 | GO:0006789 | bilirubin conjugation(GO:0006789) |
0.1 | 0.4 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
0.1 | 0.5 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.1 | GO:1903540 | neurotransmitter receptor transport to postsynaptic membrane(GO:0098969) establishment of protein localization to postsynaptic membrane(GO:1903540) |
0.1 | 0.3 | GO:0021999 | neural plate anterior/posterior regionalization(GO:0021999) |
0.1 | 0.2 | GO:0046066 | dGDP metabolic process(GO:0046066) |
0.1 | 0.5 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.8 | GO:0006491 | N-glycan processing(GO:0006491) |
0.1 | 0.3 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) |
0.1 | 1.9 | GO:0045103 | intermediate filament-based process(GO:0045103) |
0.1 | 0.5 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.9 | GO:1901750 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.0 | 0.2 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.0 | 0.2 | GO:0046697 | decidualization(GO:0046697) |
0.0 | 0.2 | GO:0035709 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.0 | 0.3 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.0 | 0.4 | GO:0031639 | plasminogen activation(GO:0031639) |
0.0 | 1.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.1 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.0 | 0.2 | GO:0006537 | glutamate biosynthetic process(GO:0006537) |
0.0 | 0.1 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.0 | 0.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.0 | 0.9 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.2 | GO:0017198 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.0 | 0.0 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.0 | GO:1904954 | canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation(GO:1904954) |
0.0 | 0.3 | GO:0016557 | peroxisome membrane biogenesis(GO:0016557) |
0.0 | 0.1 | GO:2000620 | positive regulation of histone H4-K16 acetylation(GO:2000620) |
0.0 | 0.3 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.1 | GO:0050822 | peptide stabilization(GO:0050822) peptide antigen stabilization(GO:0050823) |
0.0 | 0.3 | GO:0018879 | biphenyl metabolic process(GO:0018879) |
0.0 | 0.1 | GO:0071605 | monocyte chemotactic protein-1 production(GO:0071605) regulation of monocyte chemotactic protein-1 production(GO:0071637) |
0.0 | 0.0 | GO:1900228 | biofilm formation(GO:0042710) single-species biofilm formation(GO:0044010) single-species biofilm formation in or on host organism(GO:0044407) regulation of single-species biofilm formation(GO:1900190) negative regulation of single-species biofilm formation(GO:1900191) regulation of single-species biofilm formation in or on host organism(GO:1900228) negative regulation of single-species biofilm formation in or on host organism(GO:1900229) |
0.0 | 0.2 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.0 | 0.8 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.2 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.0 | 0.0 | GO:0006286 | base-excision repair, base-free sugar-phosphate removal(GO:0006286) |
0.0 | 0.5 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.1 | GO:1990418 | response to insulin-like growth factor stimulus(GO:1990418) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.6 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.0 | GO:0032048 | cardiolipin metabolic process(GO:0032048) |
0.0 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.0 | 0.2 | GO:0009415 | response to water(GO:0009415) |
0.0 | 0.1 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
0.0 | 0.2 | GO:0060474 | positive regulation of sperm motility involved in capacitation(GO:0060474) |
0.0 | 0.1 | GO:0097502 | mannosylation(GO:0097502) |
0.0 | 4.3 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.0 | 0.1 | GO:1902033 | regulation of hematopoietic stem cell proliferation(GO:1902033) |
0.0 | 0.2 | GO:0048243 | norepinephrine secretion(GO:0048243) |
0.0 | 0.2 | GO:0002870 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.0 | 0.2 | GO:0019732 | antifungal humoral response(GO:0019732) |
0.0 | 0.1 | GO:0097045 | phosphatidylserine exposure on blood platelet(GO:0097045) |
0.0 | 0.0 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 2.1 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.0 | 0.2 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.0 | 0.0 | GO:0051769 | nitric-oxide synthase biosynthetic process(GO:0051767) regulation of nitric-oxide synthase biosynthetic process(GO:0051769) |
0.0 | 0.1 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.2 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.0 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.0 | 0.1 | GO:2000773 | negative regulation of cellular senescence(GO:2000773) |
0.0 | 0.0 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.2 | GO:2000371 | regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000371) positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity(GO:2000373) |
0.0 | 0.2 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) |
0.0 | 0.1 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.0 | 0.1 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.0 | 0.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.0 | 0.4 | GO:0002385 | mucosal immune response(GO:0002385) |
0.0 | 0.2 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.0 | 0.2 | GO:0071025 | RNA surveillance(GO:0071025) |
0.0 | 2.8 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
0.0 | 0.3 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.0 | 2.4 | GO:0006664 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
0.0 | 0.1 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.0 | 0.1 | GO:0016045 | detection of bacterium(GO:0016045) |
0.0 | 0.0 | GO:0018158 | protein oxidation(GO:0018158) |
0.0 | 1.3 | GO:0098840 | protein transport along microtubule(GO:0098840) |
0.0 | 0.3 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.0 | 0.1 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.0 | 0.2 | GO:0031111 | negative regulation of microtubule polymerization or depolymerization(GO:0031111) |
0.0 | 0.1 | GO:0010265 | SCF complex assembly(GO:0010265) |
0.0 | 0.5 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
0.0 | 1.6 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.0 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.0 | 0.9 | GO:1901880 | negative regulation of protein depolymerization(GO:1901880) |
0.0 | 0.1 | GO:2000672 | regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.8 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
0.0 | 0.7 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.0 | 0.1 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.0 | 0.1 | GO:0051974 | negative regulation of telomerase activity(GO:0051974) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
0.0 | 0.5 | GO:1901077 | regulation of relaxation of muscle(GO:1901077) |
0.0 | 0.1 | GO:0045136 | development of secondary sexual characteristics(GO:0045136) |
0.0 | 0.3 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 2.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.0 | 0.1 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.0 | 0.1 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.0 | 0.1 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.0 | 0.1 | GO:0090035 | regulation of chaperone-mediated protein complex assembly(GO:0090034) positive regulation of chaperone-mediated protein complex assembly(GO:0090035) |
0.0 | 0.0 | GO:0038109 | response to stem cell factor(GO:0036215) cellular response to stem cell factor stimulus(GO:0036216) Kit signaling pathway(GO:0038109) |
0.0 | 0.2 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.2 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.0 | 0.1 | GO:0021894 | cerebral cortex GABAergic interneuron development(GO:0021894) |
0.0 | 0.8 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.0 | 0.1 | GO:0042435 | indole-containing compound biosynthetic process(GO:0042435) indolalkylamine biosynthetic process(GO:0046219) |
0.0 | 0.4 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.0 | 0.1 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.0 | 0.1 | GO:1904528 | positive regulation of microtubule binding(GO:1904528) |
0.0 | 0.0 | GO:0036369 | transcription factor catabolic process(GO:0036369) |
0.0 | 0.3 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.0 | 0.0 | GO:1900138 | negative regulation of phospholipase A2 activity(GO:1900138) |
0.0 | 0.2 | GO:0014029 | neural crest formation(GO:0014029) |
0.0 | 0.1 | GO:0009757 | hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.0 | 0.5 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.0 | 0.5 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.1 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.0 | 0.1 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.0 | 0.2 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.4 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.1 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.1 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.3 | GO:0015747 | urate transport(GO:0015747) |
0.0 | 0.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.6 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.0 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.0 | 0.0 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.1 | GO:1900004 | negative regulation of serine-type endopeptidase activity(GO:1900004) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.0 | 0.0 | GO:0045423 | regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) |
0.0 | 0.1 | GO:0018032 | protein amidation(GO:0018032) |
0.0 | 0.9 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.0 | GO:0010885 | regulation of cholesterol storage(GO:0010885) |
0.0 | 0.1 | GO:0003360 | brainstem development(GO:0003360) |
0.0 | 0.1 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.1 | GO:0002501 | peptide antigen assembly with MHC protein complex(GO:0002501) |
0.0 | 0.0 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.0 | 0.3 | GO:0033139 | regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033139) |
0.0 | 0.1 | GO:0042573 | retinoic acid metabolic process(GO:0042573) |
0.0 | 0.1 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.2 | GO:1904896 | ESCRT complex disassembly(GO:1904896) ESCRT III complex disassembly(GO:1904903) |
0.0 | 0.3 | GO:0045948 | positive regulation of translational initiation(GO:0045948) |
0.0 | 0.1 | GO:0018874 | benzoate metabolic process(GO:0018874) |
0.0 | 0.2 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.0 | 0.1 | GO:0051013 | microtubule severing(GO:0051013) |
0.0 | 0.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.0 | GO:1900155 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.0 | 0.0 | GO:0042350 | GDP-L-fucose biosynthetic process(GO:0042350) |
0.0 | 0.0 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 1.5 | GO:0002576 | platelet degranulation(GO:0002576) |
0.0 | 0.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 0.3 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 0.1 | GO:0006188 | IMP biosynthetic process(GO:0006188) |
0.0 | 0.2 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0048749 | compound eye development(GO:0048749) |
0.0 | 0.1 | GO:0010310 | regulation of hydrogen peroxide metabolic process(GO:0010310) |
0.0 | 0.1 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.0 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.1 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.0 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
0.0 | 0.1 | GO:0019566 | arabinose metabolic process(GO:0019566) L-arabinose metabolic process(GO:0046373) |
0.0 | 0.1 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.1 | GO:0051026 | chiasma assembly(GO:0051026) |
0.0 | 0.0 | GO:0046010 | positive regulation of circadian sleep/wake cycle, non-REM sleep(GO:0046010) |
0.0 | 0.1 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.0 | 0.0 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.0 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.0 | 0.6 | GO:0090502 | RNA phosphodiester bond hydrolysis, endonucleolytic(GO:0090502) |
0.0 | 0.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
0.0 | 0.1 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.9 | GO:0006958 | complement activation, classical pathway(GO:0006958) |
0.0 | 0.0 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.0 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.0 | 0.1 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.0 | GO:0019858 | cytosine metabolic process(GO:0019858) |
0.0 | 0.0 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.0 | 0.0 | GO:0051598 | meiotic recombination checkpoint(GO:0051598) |
0.0 | 0.3 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) |
0.0 | 0.1 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.0 | 0.0 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 0.0 | GO:0007525 | somatic muscle development(GO:0007525) |
0.0 | 0.1 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.3 | GO:0014066 | regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.1 | 9.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) symbiont-containing vacuole membrane(GO:0020005) |
2.9 | 11.7 | GO:1990796 | photoreceptor cell terminal bouton(GO:1990796) |
2.1 | 55.4 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
1.9 | 9.6 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.8 | 10.5 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
1.6 | 17.2 | GO:0097443 | sorting endosome(GO:0097443) |
1.5 | 1.5 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.5 | 7.5 | GO:0032449 | CBM complex(GO:0032449) |
1.4 | 5.5 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
1.2 | 3.7 | GO:0055028 | cortical microtubule(GO:0055028) |
1.1 | 4.5 | GO:0097196 | Shu complex(GO:0097196) |
1.0 | 16.0 | GO:0000124 | SAGA complex(GO:0000124) |
1.0 | 6.8 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.9 | 2.6 | GO:0072563 | endothelial microparticle(GO:0072563) |
0.9 | 4.4 | GO:0097513 | myosin II filament(GO:0097513) |
0.8 | 2.4 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
0.8 | 7.1 | GO:0097470 | ribbon synapse(GO:0097470) |
0.8 | 3.0 | GO:0032301 | MutSalpha complex(GO:0032301) |
0.7 | 2.2 | GO:0070762 | nuclear pore transmembrane ring(GO:0070762) |
0.7 | 0.7 | GO:0019034 | viral replication complex(GO:0019034) |
0.7 | 2.1 | GO:0039714 | viral factory(GO:0039713) cytoplasmic viral factory(GO:0039714) host cell viral assembly compartment(GO:0072517) |
0.7 | 4.2 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.7 | 4.2 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.7 | 15.0 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.7 | 2.0 | GO:0005608 | laminin-3 complex(GO:0005608) |
0.7 | 2.7 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.7 | 6.6 | GO:0016589 | NURF complex(GO:0016589) |
0.6 | 4.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.6 | 1.2 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.6 | 2.4 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.6 | 1.7 | GO:0034676 | integrin alpha6-beta4 complex(GO:0034676) |
0.6 | 12.4 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.6 | 7.3 | GO:0016600 | flotillin complex(GO:0016600) |
0.6 | 33.5 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.6 | 2.2 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.5 | 9.3 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.5 | 1.5 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.5 | 2.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.5 | 2.5 | GO:0071458 | integral component of cytoplasmic side of endoplasmic reticulum membrane(GO:0071458) |
0.5 | 4.5 | GO:0005955 | calcineurin complex(GO:0005955) |
0.5 | 3.4 | GO:0097013 | phagocytic vesicle lumen(GO:0097013) |
0.5 | 1.4 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
0.5 | 1.9 | GO:0060199 | clathrin-sculpted glutamate transport vesicle(GO:0060199) clathrin-sculpted glutamate transport vesicle membrane(GO:0060203) |
0.5 | 1.9 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.5 | 13.8 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.5 | 9.0 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
0.5 | 4.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 4.2 | GO:1990761 | growth cone lamellipodium(GO:1990761) |
0.5 | 3.2 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.4 | 5.1 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 2.1 | GO:0000125 | PCAF complex(GO:0000125) |
0.4 | 2.8 | GO:1990589 | ATF4-CREB1 transcription factor complex(GO:1990589) |
0.4 | 0.4 | GO:0032302 | MutSbeta complex(GO:0032302) |
0.4 | 0.8 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
0.4 | 1.5 | GO:0043293 | apoptosome(GO:0043293) |
0.4 | 1.1 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.4 | 0.4 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.4 | 1.1 | GO:0005940 | septin ring(GO:0005940) septin collar(GO:0032173) |
0.4 | 1.5 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
0.4 | 1.1 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
0.4 | 1.1 | GO:0036387 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.4 | 6.2 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.4 | 1.8 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.4 | 1.1 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.4 | 23.6 | GO:0031907 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
0.4 | 2.9 | GO:0071953 | elastic fiber(GO:0071953) |
0.4 | 1.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.4 | 0.7 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
0.4 | 2.9 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 3.2 | GO:0070033 | synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex(GO:0070033) |
0.4 | 12.5 | GO:0000145 | exocyst(GO:0000145) |
0.4 | 1.8 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.4 | 1.4 | GO:0031673 | H zone(GO:0031673) |
0.3 | 3.8 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.3 | 2.4 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.3 | 3.8 | GO:0016011 | dystroglycan complex(GO:0016011) |
0.3 | 1.0 | GO:0034272 | phosphatidylinositol 3-kinase complex, class III, type I(GO:0034271) phosphatidylinositol 3-kinase complex, class III, type II(GO:0034272) |
0.3 | 20.8 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.3 | 1.4 | GO:0031251 | PAN complex(GO:0031251) |
0.3 | 4.8 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.3 | 5.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.3 | 4.4 | GO:0034464 | BBSome(GO:0034464) |
0.3 | 1.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.3 | 1.3 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.3 | 5.3 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 4.2 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.3 | 1.0 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.3 | 5.1 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.9 | GO:0008275 | gamma-tubulin small complex(GO:0008275) |
0.3 | 2.2 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.3 | 1.3 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
0.3 | 0.3 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.3 | 1.2 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.3 | 1.8 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.3 | 8.9 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.3 | 0.3 | GO:1990682 | CSF1-CSF1R complex(GO:1990682) |
0.3 | 10.3 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.3 | 2.1 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.3 | 1.8 | GO:1990131 | Gtr1-Gtr2 GTPase complex(GO:1990131) |
0.3 | 7.3 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.3 | 0.9 | GO:0009330 | DNA topoisomerase complex (ATP-hydrolyzing)(GO:0009330) |
0.3 | 1.1 | GO:0034751 | aryl hydrocarbon receptor complex(GO:0034751) |
0.3 | 2.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.3 | 2.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.3 | 0.8 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.3 | 1.4 | GO:0000308 | cytoplasmic cyclin-dependent protein kinase holoenzyme complex(GO:0000308) |
0.3 | 2.1 | GO:0051286 | cell tip(GO:0051286) |
0.3 | 2.9 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.3 | 1.9 | GO:0001740 | Barr body(GO:0001740) |
0.3 | 1.8 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.3 | 0.3 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
0.3 | 3.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.3 | 1.6 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.3 | 0.8 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.3 | 2.0 | GO:0001940 | male pronucleus(GO:0001940) |
0.3 | 1.0 | GO:0045273 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 3.0 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 3.2 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.2 | 1.2 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 3.2 | GO:0097386 | glial cell projection(GO:0097386) |
0.2 | 0.7 | GO:0071745 | IgA immunoglobulin complex(GO:0071745) IgA immunoglobulin complex, circulating(GO:0071746) monomeric IgA immunoglobulin complex(GO:0071748) polymeric IgA immunoglobulin complex(GO:0071749) secretory IgA immunoglobulin complex(GO:0071751) |
0.2 | 1.4 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.2 | 2.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 9.5 | GO:0099738 | cell cortex region(GO:0099738) |
0.2 | 0.9 | GO:0005846 | nuclear cap binding complex(GO:0005846) |
0.2 | 0.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 2.1 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 4.5 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
0.2 | 0.7 | GO:0031166 | integral component of vacuolar membrane(GO:0031166) |
0.2 | 0.9 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.2 | 1.2 | GO:1990246 | uniplex complex(GO:1990246) |
0.2 | 4.1 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 3.0 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.2 | 0.7 | GO:0000814 | ESCRT II complex(GO:0000814) |
0.2 | 0.7 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.2 | 7.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.2 | 3.4 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.6 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.2 | 0.9 | GO:0097224 | sperm connecting piece(GO:0097224) |
0.2 | 1.9 | GO:0071546 | pi-body(GO:0071546) |
0.2 | 1.5 | GO:0033503 | HULC complex(GO:0033503) |
0.2 | 1.5 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.2 | 1.1 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.2 | 3.1 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.2 | 1.3 | GO:0000221 | vacuolar proton-transporting V-type ATPase, V1 domain(GO:0000221) |
0.2 | 1.9 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 1.6 | GO:0032541 | cortical endoplasmic reticulum(GO:0032541) |
0.2 | 0.6 | GO:0044352 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.2 | 1.6 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.2 | 0.4 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.2 | 5.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.2 | 1.8 | GO:0071986 | Ragulator complex(GO:0071986) |
0.2 | 1.8 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
0.2 | 1.9 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 6.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.2 | 1.0 | GO:0002169 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.2 | 0.9 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.2 | 0.6 | GO:0031143 | pseudopodium(GO:0031143) |
0.2 | 1.3 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.2 | 0.6 | GO:0034657 | GID complex(GO:0034657) |
0.2 | 29.2 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.2 | 0.9 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 4.9 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.2 | 1.1 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.2 | 0.7 | GO:0032982 | myosin filament(GO:0032982) |
0.2 | 0.6 | GO:0097361 | CIA complex(GO:0097361) |
0.2 | 0.7 | GO:0032798 | Swi5-Sfr1 complex(GO:0032798) |
0.2 | 3.8 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 1.5 | GO:0031211 | serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.2 | 4.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 5.9 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.2 | 3.0 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
0.2 | 0.9 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.2 | 0.9 | GO:0008091 | spectrin(GO:0008091) |
0.2 | 4.1 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.5 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.2 | 1.8 | GO:0042587 | glycogen granule(GO:0042587) |
0.2 | 1.9 | GO:0097433 | dense body(GO:0097433) |
0.2 | 3.3 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.2 | 3.1 | GO:0031089 | platelet dense granule lumen(GO:0031089) |
0.2 | 1.0 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.9 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.2 | 1.0 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.2 | 0.3 | GO:0034686 | integrin alphav-beta8 complex(GO:0034686) |
0.2 | 2.2 | GO:0032039 | integrator complex(GO:0032039) |
0.2 | 1.7 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.2 | 0.2 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.2 | 0.8 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
0.2 | 1.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.2 | 2.6 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.2 | 0.5 | GO:0043291 | RAVE complex(GO:0043291) |
0.2 | 1.3 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.2 | 1.8 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.2 | 1.5 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.2 | 13.2 | GO:0031672 | A band(GO:0031672) |
0.2 | 1.6 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.2 | 1.8 | GO:0005688 | U6 snRNP(GO:0005688) |
0.2 | 13.5 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.2 | 0.9 | GO:0071817 | MMXD complex(GO:0071817) |
0.2 | 1.2 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.2 | 2.2 | GO:0042588 | zymogen granule(GO:0042588) |
0.2 | 0.8 | GO:0031905 | early endosome lumen(GO:0031905) |
0.2 | 9.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 0.5 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.1 | 1.0 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 3.2 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.6 | GO:0031310 | intrinsic component of vacuolar membrane(GO:0031310) |
0.1 | 0.6 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.4 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 3.6 | GO:0016580 | Sin3 complex(GO:0016580) |
0.1 | 3.0 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 0.4 | GO:0001534 | radial spoke(GO:0001534) |
0.1 | 9.0 | GO:0045271 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 16.0 | GO:0030018 | Z disc(GO:0030018) |
0.1 | 2.1 | GO:0030008 | TRAPP complex(GO:0030008) |
0.1 | 1.0 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.1 | 0.9 | GO:0033162 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 0.4 | GO:0034678 | integrin alpha8-beta1 complex(GO:0034678) |
0.1 | 3.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.1 | 1.4 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.9 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 9.1 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.1 | 1.2 | GO:0000322 | storage vacuole(GO:0000322) |
0.1 | 5.1 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 2.2 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
0.1 | 12.1 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.6 | GO:0005602 | complement component C1 complex(GO:0005602) |
0.1 | 1.0 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
0.1 | 0.3 | GO:0071821 | FANCM-MHF complex(GO:0071821) |
0.1 | 0.7 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) |
0.1 | 1.4 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.7 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.1 | 2.3 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 1.0 | GO:0005579 | membrane attack complex(GO:0005579) |
0.1 | 0.9 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.3 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 0.2 | GO:0097182 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.1 | 5.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.1 | 0.5 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.1 | 0.2 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.1 | 0.3 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
0.1 | 2.8 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 0.4 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 0.8 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
0.1 | 0.1 | GO:0042721 | mitochondrial inner membrane protein insertion complex(GO:0042721) |
0.1 | 4.7 | GO:0060170 | ciliary membrane(GO:0060170) |
0.1 | 1.3 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 9.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.1 | 2.8 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
0.1 | 0.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 2.5 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 8.2 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:1990923 | PET complex(GO:1990923) |
0.1 | 1.5 | GO:0031105 | septin complex(GO:0031105) |
0.1 | 6.1 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 0.3 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.1 | 1.6 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.1 | 0.8 | GO:0000796 | condensin complex(GO:0000796) |
0.1 | 14.6 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 1.1 | GO:0097025 | MPP7-DLG1-LIN7 complex(GO:0097025) |
0.1 | 0.6 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.1 | 4.2 | GO:0035579 | specific granule membrane(GO:0035579) |
0.1 | 0.3 | GO:0044611 | nuclear pore inner ring(GO:0044611) |
0.1 | 2.2 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
0.1 | 0.1 | GO:0045261 | proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 1.8 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.3 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.1 | 0.3 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
0.1 | 0.7 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.1 | 2.4 | GO:0030315 | T-tubule(GO:0030315) |
0.1 | 0.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 2.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.1 | 0.2 | GO:0030849 | autosome(GO:0030849) |
0.1 | 8.1 | GO:0005814 | centriole(GO:0005814) |
0.1 | 1.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.1 | 0.7 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.3 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
0.1 | 2.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 1.5 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.7 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.1 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 1.1 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 2.9 | GO:0043198 | dendritic shaft(GO:0043198) |
0.1 | 0.4 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
0.1 | 0.7 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.1 | 1.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 1.1 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.1 | 0.1 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.1 | 0.5 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.2 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.3 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.2 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.1 | 0.9 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 0.4 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
0.1 | 0.1 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.1 | 0.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.2 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.1 | 26.5 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
0.1 | 2.2 | GO:0016459 | myosin complex(GO:0016459) |
0.1 | 0.4 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 22.8 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 4.1 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.1 | 0.3 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.1 | GO:0097233 | lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
0.1 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.1 | 1.8 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0036128 | CatSper complex(GO:0036128) |
0.0 | 1.7 | GO:0031513 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
0.0 | 0.2 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.0 | 0.2 | GO:0002177 | manchette(GO:0002177) |
0.0 | 0.4 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.0 | 0.7 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.0 | 0.5 | GO:0071682 | endocytic vesicle lumen(GO:0071682) |
0.0 | 1.3 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.0 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.6 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.0 | 0.8 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.0 | 0.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.0 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.0 | 0.6 | GO:0043034 | costamere(GO:0043034) |
0.0 | 0.4 | GO:0045240 | dihydrolipoyl dehydrogenase complex(GO:0045240) oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.2 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.2 | GO:0070822 | Sin3-type complex(GO:0070822) |
0.0 | 0.3 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 2.8 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 4.2 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.2 | GO:0070876 | SOSS complex(GO:0070876) |
0.0 | 1.7 | GO:0045171 | intercellular bridge(GO:0045171) |
0.0 | 3.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.5 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.0 | 0.2 | GO:0031515 | tRNA (m1A) methyltransferase complex(GO:0031515) |
0.0 | 0.4 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.0 | 0.0 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.0 | 0.1 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.0 | 0.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.0 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 9.6 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 0.3 | GO:0044615 | nuclear pore nuclear basket(GO:0044615) |
0.0 | 0.5 | GO:0000346 | transcription export complex(GO:0000346) |
0.0 | 4.7 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 14.8 | GO:0005925 | focal adhesion(GO:0005925) |
0.0 | 0.4 | GO:0005921 | gap junction(GO:0005921) |
0.0 | 0.1 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.0 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.0 | 0.1 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.0 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.0 | 0.2 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.2 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.0 | 0.1 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 1.0 | GO:0019814 | immunoglobulin complex(GO:0019814) immunoglobulin complex, circulating(GO:0042571) |
0.0 | 0.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.0 | 0.0 | GO:0071020 | post-spliceosomal complex(GO:0071020) |
0.0 | 0.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.0 | 5.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.0 | GO:0042581 | specific granule(GO:0042581) |
0.0 | 0.1 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
0.0 | 0.1 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.0 | 0.3 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 0.2 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.0 | 0.1 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
0.0 | 0.2 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 0.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.0 | 0.1 | GO:0099634 | postsynaptic specialization membrane(GO:0099634) |
0.0 | 0.7 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
0.0 | 0.1 | GO:0031298 | replication fork protection complex(GO:0031298) |
0.0 | 0.0 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.0 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
0.0 | 0.0 | GO:0031094 | platelet dense tubular network(GO:0031094) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 9.1 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
2.4 | 7.1 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
2.3 | 21.1 | GO:0001225 | RNA polymerase II transcription coactivator binding(GO:0001225) |
2.3 | 25.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
2.2 | 13.3 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
2.1 | 8.4 | GO:0050262 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
2.1 | 55.4 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
2.0 | 10.2 | GO:0008934 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
1.9 | 5.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
1.8 | 5.4 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
1.8 | 5.4 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
1.7 | 10.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
1.7 | 5.1 | GO:0004103 | choline kinase activity(GO:0004103) |
1.6 | 4.9 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
1.6 | 4.9 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
1.5 | 4.4 | GO:0015227 | acyl carnitine transmembrane transporter activity(GO:0015227) |
1.5 | 5.9 | GO:0004356 | glutamate-ammonia ligase activity(GO:0004356) ammonia ligase activity(GO:0016211) acid-ammonia (or amide) ligase activity(GO:0016880) |
1.4 | 2.8 | GO:0004464 | leukotriene-C4 synthase activity(GO:0004464) |
1.3 | 5.3 | GO:0003896 | DNA primase activity(GO:0003896) |
1.3 | 3.9 | GO:0050613 | delta14-sterol reductase activity(GO:0050613) |
1.2 | 16.1 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.2 | 3.6 | GO:0004137 | deoxycytidine kinase activity(GO:0004137) |
1.2 | 8.4 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
1.2 | 4.7 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.2 | 3.6 | GO:0050659 | N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity(GO:0050659) |
1.1 | 3.4 | GO:0034188 | apolipoprotein A-I receptor activity(GO:0034188) phosphatidylserine-translocating ATPase activity(GO:0090556) |
1.1 | 3.3 | GO:0004574 | oligo-1,6-glucosidase activity(GO:0004574) |
1.1 | 2.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.0 | 17.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
1.0 | 11.2 | GO:0050544 | arachidonic acid binding(GO:0050544) |
1.0 | 1.0 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
1.0 | 4.0 | GO:0043398 | HLH domain binding(GO:0043398) |
1.0 | 4.0 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) |
1.0 | 5.9 | GO:1903135 | cupric ion binding(GO:1903135) |
1.0 | 3.9 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
1.0 | 6.8 | GO:0097643 | amylin receptor activity(GO:0097643) |
1.0 | 2.9 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.9 | 6.6 | GO:0052851 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.9 | 2.8 | GO:0031780 | corticotropin hormone receptor binding(GO:0031780) type 5 melanocortin receptor binding(GO:0031783) |
0.9 | 2.8 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
0.9 | 4.6 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.9 | 2.8 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
0.9 | 4.5 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.9 | 7.2 | GO:0015923 | mannosidase activity(GO:0015923) |
0.9 | 6.3 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.9 | 2.6 | GO:0016781 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.9 | 4.3 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.9 | 0.9 | GO:0052812 | phosphatidylinositol-3,4-bisphosphate 5-kinase activity(GO:0052812) |
0.8 | 3.4 | GO:0003989 | acetyl-CoA carboxylase activity(GO:0003989) |
0.8 | 10.7 | GO:0070700 | BMP receptor binding(GO:0070700) |
0.8 | 2.5 | GO:0052857 | NADHX epimerase activity(GO:0052856) NADPHX epimerase activity(GO:0052857) |
0.8 | 2.4 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.8 | 6.4 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.8 | 2.4 | GO:0047273 | galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity(GO:0047273) |
0.8 | 3.9 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.8 | 4.7 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
0.8 | 3.0 | GO:0032143 | single thymine insertion binding(GO:0032143) |
0.8 | 3.8 | GO:0050436 | microfibril binding(GO:0050436) |
0.8 | 3.8 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.7 | 3.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.7 | 2.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.7 | 22.5 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.7 | 1.4 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.7 | 2.1 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
0.7 | 3.6 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
0.7 | 3.6 | GO:0019144 | ADP-sugar diphosphatase activity(GO:0019144) |
0.7 | 4.2 | GO:0039552 | RIG-I binding(GO:0039552) |
0.7 | 5.6 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.7 | 4.2 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.7 | 4.1 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.7 | 2.7 | GO:0043812 | phosphatidylinositol-4-phosphate phosphatase activity(GO:0043812) |
0.7 | 1.3 | GO:0008263 | pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
0.7 | 2.0 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.7 | 2.7 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.6 | 1.9 | GO:0008798 | beta-aspartyl-peptidase activity(GO:0008798) |
0.6 | 7.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
0.6 | 3.8 | GO:0008940 | nitrate reductase activity(GO:0008940) |
0.6 | 1.3 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.6 | 5.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.6 | 1.8 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.6 | 3.6 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.6 | 3.6 | GO:0052841 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) inositol diphosphate tetrakisphosphate diphosphatase activity(GO:0052840) inositol bisdiphosphate tetrakisphosphate diphosphatase activity(GO:0052841) inositol diphosphate pentakisphosphate diphosphatase activity(GO:0052842) inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity(GO:0052843) inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity(GO:0052844) inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity(GO:0052845) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity(GO:0052846) inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052847) inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity(GO:0052848) |
0.6 | 3.0 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.6 | 0.6 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.6 | 3.5 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.6 | 4.7 | GO:0009374 | biotin binding(GO:0009374) |
0.6 | 3.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.6 | 2.3 | GO:0001512 | dihydronicotinamide riboside quinone reductase activity(GO:0001512) melatonin binding(GO:1904408) |
0.6 | 6.9 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.6 | 11.5 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.6 | 1.7 | GO:0004560 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.6 | 1.7 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.6 | 1.7 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.6 | 2.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.6 | 1.7 | GO:0004170 | dUTP diphosphatase activity(GO:0004170) |
0.6 | 1.7 | GO:0001160 | transcription termination site sequence-specific DNA binding(GO:0001147) transcription termination site DNA binding(GO:0001160) |
0.6 | 1.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.6 | 1.7 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.6 | 2.8 | GO:0070905 | serine binding(GO:0070905) |
0.6 | 11.1 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.6 | 1.7 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.6 | 2.2 | GO:0003867 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.6 | 3.3 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.5 | 4.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.5 | 1.6 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
0.5 | 3.3 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.5 | 2.2 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.5 | 0.5 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.5 | 2.1 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.5 | 0.5 | GO:0035939 | microsatellite binding(GO:0035939) |
0.5 | 4.2 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.5 | 1.6 | GO:0005169 | neurotrophin TRKB receptor binding(GO:0005169) |
0.5 | 1.6 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.5 | 2.6 | GO:0004348 | glucosylceramidase activity(GO:0004348) |
0.5 | 2.6 | GO:0017040 | ceramidase activity(GO:0017040) |
0.5 | 1.0 | GO:0004819 | glutamine-tRNA ligase activity(GO:0004819) |
0.5 | 2.6 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.5 | 3.6 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
0.5 | 2.6 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.5 | 5.1 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.5 | 1.5 | GO:0008457 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
0.5 | 3.1 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.5 | 7.2 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.5 | 2.5 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
0.5 | 3.6 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.5 | 1.5 | GO:0010309 | acireductone dioxygenase [iron(II)-requiring] activity(GO:0010309) |
0.5 | 2.5 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.5 | 6.5 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.5 | 5.9 | GO:0031386 | protein tag(GO:0031386) |
0.5 | 2.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.5 | 2.4 | GO:0032810 | sterol response element binding(GO:0032810) |
0.5 | 1.9 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.5 | 1.5 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.5 | 4.4 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.5 | 4.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.5 | 1.4 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.5 | 1.9 | GO:0017099 | very-long-chain-acyl-CoA dehydrogenase activity(GO:0017099) |
0.5 | 1.9 | GO:0004057 | arginyltransferase activity(GO:0004057) |
0.5 | 1.4 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.5 | 1.4 | GO:0004779 | adenylylsulfate kinase activity(GO:0004020) sulfate adenylyltransferase activity(GO:0004779) sulfate adenylyltransferase (ATP) activity(GO:0004781) |
0.5 | 1.9 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
0.5 | 1.4 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.5 | 2.3 | GO:0004705 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
0.5 | 2.3 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.5 | 6.8 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.5 | 4.5 | GO:0042731 | PH domain binding(GO:0042731) |
0.4 | 1.3 | GO:0001181 | transcription factor activity, core RNA polymerase I binding(GO:0001181) |
0.4 | 1.8 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
0.4 | 4.9 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.4 | 0.4 | GO:0005168 | neurotrophin TRK receptor binding(GO:0005167) neurotrophin TRKA receptor binding(GO:0005168) |
0.4 | 1.3 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
0.4 | 5.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.4 | 1.3 | GO:0031071 | cysteine desulfurase activity(GO:0031071) |
0.4 | 4.0 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
0.4 | 1.8 | GO:0070404 | NADH binding(GO:0070404) |
0.4 | 1.3 | GO:0004915 | interleukin-6 receptor activity(GO:0004915) interleukin-6 binding(GO:0019981) |
0.4 | 0.4 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 1.3 | GO:0003955 | NAD(P)H dehydrogenase (quinone) activity(GO:0003955) |
0.4 | 2.2 | GO:0016454 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.4 | 3.0 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.4 | 2.2 | GO:0047057 | oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor(GO:0016900) vitamin-K-epoxide reductase (warfarin-sensitive) activity(GO:0047057) |
0.4 | 0.9 | GO:0008469 | histone-arginine N-methyltransferase activity(GO:0008469) |
0.4 | 14.1 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.4 | 2.1 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.4 | 1.7 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.4 | 3.8 | GO:0048039 | ubiquinone binding(GO:0048039) |
0.4 | 2.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.4 | 2.1 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.4 | 0.8 | GO:0032139 | dinucleotide insertion or deletion binding(GO:0032139) |
0.4 | 11.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.4 | 1.7 | GO:0008112 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.4 | 1.7 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
0.4 | 1.2 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.4 | 3.7 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 5.3 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.4 | 1.6 | GO:0051996 | farnesyl-diphosphate farnesyltransferase activity(GO:0004310) squalene synthase activity(GO:0051996) |
0.4 | 3.7 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.4 | 1.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.4 | 2.9 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.4 | 1.2 | GO:0098782 | mechanically-gated potassium channel activity(GO:0098782) |
0.4 | 0.8 | GO:0044388 | small protein activating enzyme binding(GO:0044388) |
0.4 | 1.6 | GO:0004782 | sulfinoalanine decarboxylase activity(GO:0004782) |
0.4 | 0.4 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.4 | 1.2 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.4 | 8.3 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.4 | 0.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.4 | 0.8 | GO:0008665 | 2'-phosphotransferase activity(GO:0008665) |
0.4 | 1.2 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.4 | 2.4 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.4 | 2.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.4 | 1.2 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.4 | 2.0 | GO:0004306 | ethanolamine-phosphate cytidylyltransferase activity(GO:0004306) |
0.4 | 1.2 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.4 | 1.2 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.4 | 3.1 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.4 | 3.5 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
0.4 | 3.5 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
0.4 | 1.5 | GO:0008431 | vitamin E binding(GO:0008431) |
0.4 | 3.0 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.4 | 0.4 | GO:0032089 | NACHT domain binding(GO:0032089) |
0.4 | 2.6 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 6.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.4 | 1.5 | GO:0047708 | biotinidase activity(GO:0047708) |
0.4 | 3.4 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.4 | 3.4 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
0.4 | 1.8 | GO:0016019 | peptidoglycan receptor activity(GO:0016019) |
0.4 | 0.7 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
0.4 | 1.8 | GO:0052740 | 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
0.4 | 2.9 | GO:0003680 | AT DNA binding(GO:0003680) |
0.4 | 1.5 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
0.4 | 1.5 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.4 | 0.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.4 | 1.1 | GO:0090541 | MIT domain binding(GO:0090541) |
0.4 | 1.1 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
0.4 | 1.8 | GO:0017166 | vinculin binding(GO:0017166) |
0.4 | 2.2 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.4 | 5.4 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 0.7 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.4 | 7.9 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.4 | 1.1 | GO:0008955 | peptidoglycan glycosyltransferase activity(GO:0008955) |
0.4 | 1.4 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.4 | 1.4 | GO:0047066 | phospholipid-hydroperoxide glutathione peroxidase activity(GO:0047066) |
0.4 | 0.7 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.4 | 2.5 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.3 | 1.4 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
0.3 | 3.8 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.3 | 1.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 4.5 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.3 | 2.1 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.3 | 7.3 | GO:0031432 | titin binding(GO:0031432) |
0.3 | 1.0 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.3 | 1.7 | GO:0097016 | L27 domain binding(GO:0097016) |
0.3 | 3.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.3 | 2.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.3 | 0.3 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
0.3 | 0.3 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.3 | 2.6 | GO:0009008 | DNA-methyltransferase activity(GO:0009008) |
0.3 | 2.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.3 | 2.6 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 2.9 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.3 | 4.8 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.3 | 5.4 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.3 | 1.0 | GO:0032296 | ribonuclease III activity(GO:0004525) double-stranded RNA-specific ribonuclease activity(GO:0032296) |
0.3 | 1.6 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.3 | 0.9 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
0.3 | 1.6 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.3 | 0.9 | GO:0032093 | SAM domain binding(GO:0032093) |
0.3 | 2.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.3 | 1.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.3 | 5.6 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.3 | 1.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.3 | 2.8 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 0.9 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.3 | 5.2 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.3 | 1.2 | GO:0016670 | oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor(GO:0016670) |
0.3 | 1.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.3 | 2.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.3 | 4.2 | GO:0043225 | anion transmembrane-transporting ATPase activity(GO:0043225) |
0.3 | 3.9 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 0.9 | GO:0017095 | heparan sulfate 6-O-sulfotransferase activity(GO:0017095) |
0.3 | 2.1 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.3 | 3.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.3 | 1.5 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.3 | 2.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
0.3 | 2.4 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.3 | 0.6 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.3 | 1.2 | GO:0036033 | mediator complex binding(GO:0036033) |
0.3 | 2.0 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.3 | 3.8 | GO:0045159 | myosin II binding(GO:0045159) |
0.3 | 0.9 | GO:0052831 | inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol-1,3,4-trisphosphate 6-kinase activity(GO:0052725) inositol-1,3,4-trisphosphate 5-kinase activity(GO:0052726) inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity(GO:0052825) inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity(GO:0052830) inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity(GO:0052831) inositol-3,4,6-trisphosphate 1-kinase activity(GO:0052835) |
0.3 | 4.0 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.3 | 0.3 | GO:0032551 | pyrimidine nucleoside binding(GO:0001884) UTP binding(GO:0002134) pyrimidine ribonucleoside binding(GO:0032551) |
0.3 | 4.9 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.3 | 2.3 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.3 | 1.1 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.3 | 0.3 | GO:0005119 | smoothened binding(GO:0005119) |
0.3 | 3.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.3 | 2.5 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 1.1 | GO:0004335 | galactokinase activity(GO:0004335) |
0.3 | 1.1 | GO:0005477 | pyruvate secondary active transmembrane transporter activity(GO:0005477) |
0.3 | 1.1 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.3 | 7.7 | GO:0000030 | mannosyltransferase activity(GO:0000030) |
0.3 | 0.3 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.3 | 3.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.3 | 12.8 | GO:0044390 | ubiquitin-like protein conjugating enzyme binding(GO:0044390) |
0.3 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.3 | 1.4 | GO:0004337 | dimethylallyltranstransferase activity(GO:0004161) geranyltranstransferase activity(GO:0004337) |
0.3 | 0.8 | GO:0016652 | NAD(P)+ transhydrogenase activity(GO:0008746) oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor(GO:0016652) |
0.3 | 3.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.3 | 1.4 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
0.3 | 13.8 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 2.7 | GO:0071253 | connexin binding(GO:0071253) |
0.3 | 1.1 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.3 | 0.5 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
0.3 | 3.2 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 7.4 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 1.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.3 | 1.0 | GO:0001588 | dopamine neurotransmitter receptor activity, coupled via Gs(GO:0001588) |
0.3 | 0.5 | GO:0070538 | oleic acid binding(GO:0070538) |
0.3 | 3.9 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.3 | 4.6 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.3 | 0.3 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.3 | 1.0 | GO:0015375 | glycine:sodium symporter activity(GO:0015375) |
0.3 | 1.3 | GO:0004359 | glutaminase activity(GO:0004359) |
0.3 | 0.8 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.3 | 0.8 | GO:0070579 | methylcytosine dioxygenase activity(GO:0070579) |
0.3 | 2.0 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.3 | 5.6 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.3 | 1.0 | GO:0004657 | proline dehydrogenase activity(GO:0004657) |
0.3 | 4.8 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.3 | 2.3 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
0.3 | 1.0 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.3 | 5.5 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.2 | 0.7 | GO:0008267 | poly-glutamine tract binding(GO:0008267) |
0.2 | 0.7 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.2 | 0.5 | GO:0032767 | copper-dependent protein binding(GO:0032767) |
0.2 | 0.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.2 | 1.7 | GO:0099604 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 0.5 | GO:0008969 | phosphohistidine phosphatase activity(GO:0008969) |
0.2 | 2.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 1.7 | GO:0019211 | phosphatase activator activity(GO:0019211) |
0.2 | 0.5 | GO:0010340 | carboxyl-O-methyltransferase activity(GO:0010340) protein carboxyl O-methyltransferase activity(GO:0051998) |
0.2 | 2.4 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.2 | 1.4 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.2 | 5.8 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.2 | 1.6 | GO:0016413 | O-acetyltransferase activity(GO:0016413) |
0.2 | 1.4 | GO:0031821 | G-protein coupled serotonin receptor binding(GO:0031821) |
0.2 | 0.5 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.2 | 3.0 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.2 | 3.6 | GO:0030957 | Tat protein binding(GO:0030957) |
0.2 | 0.7 | GO:0042954 | lipoprotein transporter activity(GO:0042954) |
0.2 | 1.3 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.2 | 0.4 | GO:0016405 | CoA-ligase activity(GO:0016405) |
0.2 | 0.4 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.2 | 1.8 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.2 | 1.5 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.2 | 0.7 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.2 | 0.7 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.2 | 0.6 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.2 | 0.9 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
0.2 | 0.6 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.2 | 1.9 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.2 | 0.6 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.2 | 1.3 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.2 | 0.4 | GO:0052811 | 1-phosphatidylinositol-3-phosphate 4-kinase activity(GO:0052811) |
0.2 | 0.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.2 | 3.6 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 0.8 | GO:0004803 | transposase activity(GO:0004803) |
0.2 | 2.3 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.2 | 1.2 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 0.6 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.2 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 1.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.2 | 1.6 | GO:0008430 | selenium binding(GO:0008430) |
0.2 | 2.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.2 | 1.0 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.2 | 3.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.2 | 1.0 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.2 | 4.6 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 4.4 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 0.6 | GO:0047389 | glycerophosphocholine phosphodiesterase activity(GO:0047389) |
0.2 | 0.8 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
0.2 | 0.2 | GO:0070336 | flap-structured DNA binding(GO:0070336) |
0.2 | 1.2 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 11.1 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.2 | 2.9 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.2 | 3.3 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.2 | 6.7 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
0.2 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.2 | 0.6 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.2 | 0.9 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.2 | 3.2 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.2 | 0.8 | GO:0015093 | ferrous iron transmembrane transporter activity(GO:0015093) |
0.2 | 1.5 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.2 | 0.4 | GO:0097363 | protein O-GlcNAc transferase activity(GO:0097363) |
0.2 | 0.6 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.2 | 8.7 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 0.6 | GO:0003954 | NADH dehydrogenase activity(GO:0003954) |
0.2 | 3.1 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.2 | 9.9 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
0.2 | 0.7 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.2 | 4.0 | GO:0043495 | protein anchor(GO:0043495) |
0.2 | 4.4 | GO:0001223 | transcription coactivator binding(GO:0001223) |
0.2 | 0.5 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
0.2 | 2.4 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.2 | 0.7 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.2 | 2.0 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.2 | 1.1 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
0.2 | 1.6 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.2 | 3.1 | GO:0008171 | O-methyltransferase activity(GO:0008171) |
0.2 | 0.7 | GO:0061575 | cyclin-dependent protein serine/threonine kinase activator activity(GO:0061575) |
0.2 | 1.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.2 | 0.2 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.2 | 0.5 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.2 | 0.5 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.2 | 1.2 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 3.0 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.2 | 1.7 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.5 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.2 | 1.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
0.2 | 1.2 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.7 | GO:0016936 | galactoside binding(GO:0016936) |
0.2 | 0.2 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.2 | 0.5 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.2 | 0.7 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.2 | 0.9 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.2 | 0.5 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
0.2 | 1.9 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.2 | 2.2 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.2 | 0.5 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.2 | 1.3 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.2 | 1.0 | GO:0004096 | catalase activity(GO:0004096) |
0.2 | 2.3 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 1.7 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
0.2 | 0.3 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 4.3 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.2 | 1.8 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.5 | GO:0015275 | stretch-activated, cation-selective, calcium channel activity(GO:0015275) |
0.2 | 6.7 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.2 | 0.8 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.2 | 3.1 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.2 | 0.3 | GO:1990763 | arrestin family protein binding(GO:1990763) |
0.2 | 1.0 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.2 | 5.5 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.2 | 12.6 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 1.0 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.2 | 0.2 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.2 | 1.1 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.2 | 0.8 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.2 | 15.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.2 | 0.6 | GO:0000285 | 1-phosphatidylinositol-3-phosphate 5-kinase activity(GO:0000285) |
0.2 | 0.5 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.2 | 1.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.2 | 0.6 | GO:0016429 | tRNA (adenine) methyltransferase activity(GO:0016426) tRNA (adenine-N1-)-methyltransferase activity(GO:0016429) |
0.2 | 1.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.2 | 0.5 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.2 | 8.0 | GO:0035326 | enhancer binding(GO:0035326) |
0.2 | 3.1 | GO:0010857 | calcium-dependent protein kinase activity(GO:0010857) |
0.2 | 0.5 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 0.9 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.8 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.2 | 12.3 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.4 | GO:0008480 | sarcosine dehydrogenase activity(GO:0008480) |
0.1 | 4.4 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 1.2 | GO:0003995 | acyl-CoA dehydrogenase activity(GO:0003995) |
0.1 | 1.3 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 0.4 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.1 | 8.2 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.1 | 1.6 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.1 | 0.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 1.5 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.9 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.1 | 0.4 | GO:1904455 | ubiquitin-specific protease activity involved in negative regulation of ERAD pathway(GO:1904455) |
0.1 | 1.0 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.0 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.1 | 1.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
0.1 | 1.4 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.1 | 0.4 | GO:0030626 | U12 snRNA binding(GO:0030626) |
0.1 | 1.0 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 1.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 1.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 2.2 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.1 | 1.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.1 | 0.7 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 0.4 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.1 | 0.4 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.1 | 3.2 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.1 | 11.3 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.1 | 0.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 2.6 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.4 | GO:0005462 | UDP-N-acetylglucosamine transmembrane transporter activity(GO:0005462) |
0.1 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.1 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
0.1 | 2.2 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 4.0 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.4 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 3.9 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0043559 | insulin binding(GO:0043559) |
0.1 | 0.3 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
0.1 | 0.7 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 0.1 | GO:0043139 | 5'-3' DNA helicase activity(GO:0043139) |
0.1 | 0.5 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
0.1 | 0.8 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.1 | 0.6 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.5 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.9 | GO:0016403 | dimethylargininase activity(GO:0016403) |
0.1 | 0.5 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) cholestenone 5-alpha-reductase activity(GO:0047751) |
0.1 | 0.4 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.4 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 1.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.1 | 5.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.1 | 2.7 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 7.1 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.5 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 6.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.1 | 0.8 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 7.0 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 1.6 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.1 | 0.8 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.1 | 0.3 | GO:0070283 | lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
0.1 | 0.6 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
0.1 | 0.2 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.8 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.1 | 0.6 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.1 | 0.7 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.2 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.1 | 1.6 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.1 | 0.3 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.4 | GO:0004346 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.1 | 48.1 | GO:0001077 | transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001077) |
0.1 | 0.7 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 0.1 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.1 | 0.1 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.1 | 1.1 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.1 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.1 | 5.1 | GO:0019905 | syntaxin binding(GO:0019905) |
0.1 | 4.0 | GO:0051959 | dynein light intermediate chain binding(GO:0051959) |
0.1 | 0.3 | GO:0005171 | hepatocyte growth factor receptor binding(GO:0005171) |
0.1 | 1.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.1 | 0.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.1 | 1.3 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 0.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.1 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 0.7 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.1 | 0.4 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.1 | 2.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.3 | GO:0017129 | triglyceride binding(GO:0017129) |
0.1 | 0.5 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
0.1 | 0.6 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.6 | GO:0052795 | exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.1 | 1.2 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.1 | 1.0 | GO:0032052 | bile acid binding(GO:0032052) |
0.1 | 3.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.2 | GO:0032090 | Pyrin domain binding(GO:0032090) |
0.1 | 0.2 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.1 | 1.6 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.9 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.6 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
0.1 | 10.0 | GO:0004497 | monooxygenase activity(GO:0004497) |
0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 3.9 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 0.2 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.6 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.1 | 1.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.1 | 5.3 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.4 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 0.2 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.1 | 0.4 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.5 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.1 | 0.4 | GO:0016639 | oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor(GO:0016639) |
0.1 | 0.1 | GO:0043532 | angiostatin binding(GO:0043532) |
0.1 | 0.4 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
0.1 | 0.4 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.1 | 4.3 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 4.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.1 | 0.1 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.1 | 1.6 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.1 | 0.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.6 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
0.1 | 0.3 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.1 | 0.4 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
0.1 | 0.3 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.1 | 0.3 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.1 | 0.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.1 | 0.3 | GO:0000995 | transcription factor activity, core RNA polymerase III binding(GO:0000995) |
0.1 | 3.3 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
0.1 | 2.7 | GO:0031491 | nucleosome binding(GO:0031491) |
0.1 | 0.9 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.1 | 0.5 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.1 | 5.4 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.1 | 9.9 | GO:0002020 | protease binding(GO:0002020) |
0.1 | 0.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.1 | 0.2 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.1 | 0.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.1 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.2 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.1 | 0.2 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.1 | 2.0 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.1 | 0.3 | GO:0042903 | tubulin deacetylase activity(GO:0042903) |
0.1 | 0.6 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.1 | 0.6 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.7 | GO:0015925 | galactosidase activity(GO:0015925) |
0.1 | 0.4 | GO:1990189 | peptide-serine-N-acetyltransferase activity(GO:1990189) |
0.1 | 0.3 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.1 | 1.1 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.1 | 4.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.1 | 6.6 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
0.1 | 0.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.1 | 2.1 | GO:0001848 | complement binding(GO:0001848) |
0.1 | 0.4 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.8 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 1.7 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.2 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
0.1 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.2 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 3.0 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.9 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
0.1 | 1.1 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.4 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.4 | GO:0033130 | acetylcholine receptor binding(GO:0033130) |
0.1 | 2.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 1.2 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.1 | 0.1 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
0.1 | 0.7 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.1 | 0.3 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 1.1 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.1 | 0.2 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 0.3 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 0.2 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.1 | 0.3 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.1 | 0.2 | GO:0097158 | pre-mRNA intronic pyrimidine-rich binding(GO:0097158) |
0.1 | 4.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.6 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 0.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.6 | GO:0055104 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 0.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.1 | 0.2 | GO:0005113 | patched binding(GO:0005113) |
0.1 | 0.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.1 | 0.3 | GO:0030197 | extracellular matrix constituent, lubricant activity(GO:0030197) |
0.1 | 0.3 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.9 | GO:0045503 | dynein light chain binding(GO:0045503) |
0.1 | 1.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.2 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.1 | 1.6 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.1 | 0.9 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.1 | 0.1 | GO:0097001 | ceramide binding(GO:0097001) |
0.1 | 1.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 0.6 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.1 | 0.4 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.5 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.1 | 0.1 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.1 | 0.3 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.5 | GO:0016595 | glutamate binding(GO:0016595) |
0.1 | 0.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.1 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.1 | 0.9 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 0.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.1 | 0.3 | GO:0044548 | S100 protein binding(GO:0044548) |
0.1 | 1.6 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.6 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
0.1 | 0.4 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.3 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.1 | 0.3 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 2.0 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.1 | 0.9 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.9 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.1 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.9 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.1 | 0.3 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.6 | GO:0098847 | sequence-specific single stranded DNA binding(GO:0098847) |
0.1 | 1.5 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.2 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 13.3 | GO:0008134 | transcription factor binding(GO:0008134) |
0.1 | 37.0 | GO:0005509 | calcium ion binding(GO:0005509) |
0.1 | 0.9 | GO:0036374 | glutathione hydrolase activity(GO:0036374) |
0.0 | 0.8 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 0.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
0.0 | 0.3 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.1 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.0 | 0.9 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.4 | GO:0019863 | IgE binding(GO:0019863) |
0.0 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.0 | 0.2 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.1 | GO:0047374 | methylumbelliferyl-acetate deacetylase activity(GO:0047374) |
0.0 | 0.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.6 | GO:0004623 | phospholipase A2 activity(GO:0004623) |
0.0 | 0.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) |
0.0 | 0.4 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.0 | 0.1 | GO:0019958 | C-X-C chemokine binding(GO:0019958) |
0.0 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.0 | GO:0033677 | DNA/RNA helicase activity(GO:0033677) |
0.0 | 0.0 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.0 | 0.1 | GO:0034353 | RNA pyrophosphohydrolase activity(GO:0034353) |
0.0 | 0.6 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.0 | 0.2 | GO:0004982 | N-formyl peptide receptor activity(GO:0004982) |
0.0 | 0.3 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.1 | GO:0016422 | mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity(GO:0016422) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.0 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.0 | 1.3 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.0 | 2.4 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 1.0 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.7 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.0 | 0.2 | GO:0023030 | MHC class Ib protein complex binding(GO:0023025) MHC class Ib protein binding, via antigen binding groove(GO:0023030) |
0.0 | 3.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.2 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.0 | 3.6 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0033754 | indoleamine 2,3-dioxygenase activity(GO:0033754) |
0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.1 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.0 | 0.1 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.0 | 0.1 | GO:1990405 | protein antigen binding(GO:1990405) |
0.0 | 4.4 | GO:0003714 | transcription corepressor activity(GO:0003714) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 1.1 | GO:0016620 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor(GO:0016620) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.1 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.0 | 0.1 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
0.0 | 0.0 | GO:0051139 | metal ion:proton antiporter activity(GO:0051139) |
0.0 | 0.0 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.0 | 0.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.0 | 5.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.4 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
0.0 | 0.0 | GO:0045145 | single-stranded DNA 5'-3' exodeoxyribonuclease activity(GO:0045145) |
0.0 | 0.1 | GO:0001165 | RNA polymerase I upstream control element sequence-specific DNA binding(GO:0001165) |
0.0 | 2.4 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.0 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
0.0 | 0.4 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.8 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0004983 | neuropeptide Y receptor activity(GO:0004983) |
0.0 | 0.0 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.0 | 0.0 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.0 | 0.2 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.1 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.0 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
0.0 | 0.3 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.6 | GO:0004385 | guanylate kinase activity(GO:0004385) |
0.0 | 0.0 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.0 | 0.1 | GO:0015307 | drug:proton antiporter activity(GO:0015307) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.7 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.0 | GO:0016160 | amylase activity(GO:0016160) |
0.0 | 0.1 | GO:0016208 | AMP binding(GO:0016208) |
0.0 | 0.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.0 | 0.1 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.1 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.0 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.0 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.0 | 0.1 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.0 | 0.3 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.0 | 0.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 0.1 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
0.0 | 0.7 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.8 | GO:0004553 | hydrolase activity, hydrolyzing O-glycosyl compounds(GO:0004553) |
0.0 | 0.0 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.0 | 0.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 0.0 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.0 | 0.4 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.4 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.1 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.0 | 0.1 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.0 | 0.6 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.4 | GO:0017022 | myosin binding(GO:0017022) |
0.0 | 0.1 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.0 | 0.2 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.0 | 0.1 | GO:0008301 | DNA binding, bending(GO:0008301) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.1 | 20.5 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.9 | 0.9 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.8 | 2.3 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.6 | 34.0 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.5 | 2.6 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.5 | 5.2 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.4 | 1.7 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.4 | 0.8 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.4 | 6.8 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.4 | 15.9 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.4 | 2.2 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 7.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 6.7 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.3 | 4.2 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.3 | 17.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 17.3 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.3 | 9.5 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.3 | 9.7 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 6.0 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.3 | 4.4 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.3 | 21.8 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 16.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.3 | 6.5 | PID EPO PATHWAY | EPO signaling pathway |
0.3 | 0.3 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.3 | 2.8 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.3 | 0.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.3 | 16.0 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 9.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.2 | 9.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 6.3 | PID ALK1 PATHWAY | ALK1 signaling events |
0.2 | 2.8 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.2 | 6.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 4.8 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
0.2 | 7.3 | PID IGF1 PATHWAY | IGF1 pathway |
0.2 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.2 | 2.7 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 1.0 | PID ALK2 PATHWAY | ALK2 signaling events |
0.2 | 2.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.2 | 0.9 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.2 | 5.7 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 0.9 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.2 | 3.9 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.2 | 1.3 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.2 | 1.3 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.1 | 1.5 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 3.6 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.1 | 2.6 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.3 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 4.4 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 2.5 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.0 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.1 | 3.7 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.1 | 2.4 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 6.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 14.0 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.1 | 2.6 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.1 | 0.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.1 | 6.8 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 8.8 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 3.8 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 0.6 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 0.9 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.1 | 4.6 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.7 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 4.8 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 2.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.0 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 4.9 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.1 | 2.3 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.1 | 5.5 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 3.2 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.1 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 2.9 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 0.3 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.1 | 1.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 1.4 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.1 | 2.0 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 0.3 | ST INTERFERON GAMMA PATHWAY | Interferon gamma pathway. |
0.1 | 0.1 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.1 | 2.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 1.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.1 | 0.7 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 1.2 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 16.1 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 3.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.1 | 3.6 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 4.3 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 0.4 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.7 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.1 | 0.9 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.8 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 0.5 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.0 | 1.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 2.1 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 2.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.0 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 2.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.3 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.0 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.5 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.1 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 4.4 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 1.0 | REACTOME DAG AND IP3 SIGNALING | Genes involved in DAG and IP3 signaling |
0.9 | 18.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.9 | 52.6 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.8 | 1.6 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.8 | 13.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.7 | 10.4 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 4.5 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.6 | 10.9 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.6 | 9.1 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.6 | 15.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.5 | 1.6 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.5 | 22.0 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.5 | 13.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 13.5 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.5 | 0.9 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.5 | 8.9 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.5 | 8.0 | REACTOME SIGNALING BY NOTCH4 | Genes involved in Signaling by NOTCH4 |
0.5 | 17.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.5 | 3.7 | REACTOME ACYL CHAIN REMODELLING OF PC | Genes involved in Acyl chain remodelling of PC |
0.5 | 0.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.4 | 2.2 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.4 | 6.8 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.4 | 13.3 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.4 | 1.6 | REACTOME BOTULINUM NEUROTOXICITY | Genes involved in Botulinum neurotoxicity |
0.4 | 2.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 2.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.4 | 7.0 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.4 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.4 | 2.2 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.4 | 12.2 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.4 | 13.1 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.3 | 21.7 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.3 | 8.7 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 6.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.3 | 8.1 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 8.0 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.3 | 5.1 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.3 | 0.3 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.3 | 0.6 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.3 | 7.0 | REACTOME CREB PHOSPHORYLATION THROUGH THE ACTIVATION OF CAMKII | Genes involved in CREB phosphorylation through the activation of CaMKII |
0.3 | 0.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.3 | 5.7 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.3 | 5.3 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.3 | 6.6 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.3 | 2.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.3 | 5.3 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.3 | 11.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.3 | 1.0 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.3 | 3.9 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 1.0 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.3 | 3.5 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.3 | 5.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.2 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.2 | 8.2 | REACTOME SIGNALING BY FGFR1 MUTANTS | Genes involved in Signaling by FGFR1 mutants |
0.2 | 8.5 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.2 | 3.9 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.2 | 6.0 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 7.0 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.2 | 3.6 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.2 | 3.3 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 4.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.2 | 3.0 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.2 | 6.4 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.2 | 16.2 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.2 | 4.7 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.2 | 1.8 | REACTOME ADENYLATE CYCLASE INHIBITORY PATHWAY | Genes involved in Adenylate cyclase inhibitory pathway |
0.2 | 9.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.2 | 1.0 | REACTOME CA DEPENDENT EVENTS | Genes involved in Ca-dependent events |
0.2 | 19.0 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.2 | 1.5 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.2 | 1.1 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.2 | 6.2 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 7.7 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.2 | 3.1 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.2 | 5.4 | REACTOME INSULIN SYNTHESIS AND PROCESSING | Genes involved in Insulin Synthesis and Processing |
0.2 | 5.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.2 | 0.2 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.2 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.2 | 6.3 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.2 | 10.1 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.2 | 7.0 | REACTOME GLOBAL GENOMIC NER GG NER | Genes involved in Global Genomic NER (GG-NER) |
0.2 | 4.2 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.2 | 3.8 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.2 | 14.3 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 3.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.2 | 2.1 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.2 | 7.9 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.2 | 3.2 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.2 | 0.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.2 | 2.6 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.2 | 2.7 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 3.1 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 0.7 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 2.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 1.7 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.8 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.1 | 4.8 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.1 | 0.7 | REACTOME RETROGRADE NEUROTROPHIN SIGNALLING | Genes involved in Retrograde neurotrophin signalling |
0.1 | 4.1 | REACTOME ADP SIGNALLING THROUGH P2RY1 | Genes involved in ADP signalling through P2Y purinoceptor 1 |
0.1 | 1.2 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.1 | 2.7 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.1 | 2.7 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 7.8 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.1 | 0.7 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.1 | 9.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 9.0 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.1 | 3.1 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 2.8 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 4.2 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 3.6 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 1.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 8.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.1 | 1.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.1 | 1.8 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 8.3 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 1.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.1 | 2.5 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.3 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.1 | 0.5 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.1 | 1.7 | REACTOME SIGNALING BY FGFR MUTANTS | Genes involved in Signaling by FGFR mutants |
0.1 | 0.8 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.1 | 13.6 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 0.2 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 3.3 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.3 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.3 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 3.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.1 | 0.6 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.1 | 3.2 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 1.4 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 12.6 | REACTOME FATTY ACID TRIACYLGLYCEROL AND KETONE BODY METABOLISM | Genes involved in Fatty acid, triacylglycerol, and ketone body metabolism |
0.1 | 2.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.6 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.0 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.1 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.1 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.1 | 1.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.1 | 0.6 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.1 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.1 | 0.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.0 | 1.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 1.0 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.0 | 0.5 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.0 | 3.3 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 1.9 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 1.2 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 1.0 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.9 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.5 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 1.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME VIRAL MESSENGER RNA SYNTHESIS | Genes involved in Viral Messenger RNA Synthesis |
0.0 | 0.1 | REACTOME NUCLEOTIDE EXCISION REPAIR | Genes involved in Nucleotide Excision Repair |
0.0 | 0.9 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.0 | 0.0 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 1.9 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.4 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.0 | 0.4 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.0 | 0.9 | REACTOME REGULATION OF INSULIN SECRETION | Genes involved in Regulation of Insulin Secretion |
0.0 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.7 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 1.3 | REACTOME NCAM SIGNALING FOR NEURITE OUT GROWTH | Genes involved in NCAM signaling for neurite out-growth |
0.0 | 0.7 | REACTOME DNA REPAIR | Genes involved in DNA Repair |
0.0 | 0.3 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.0 | 0.2 | REACTOME EARLY PHASE OF HIV LIFE CYCLE | Genes involved in Early Phase of HIV Life Cycle |